Document:

EXHIBIT 10.1

 

SEPARATION, TRANSITION AND CONSULTING AGREEMENT

 

THIS SEPARATION, TRANSITION
AND CONSULTING AGREEMENT (this “Agreement”) is entered into on this 6th day of October, 2017
(the “Effective Date”), by and between MRI Interventions, Inc.,
a Delaware corporation (the “Company”), and FRANCIS P. GRILLO (“Grillo”).

 

W I T N E S S E T H:

 

WHEREAS, Grillo
has served as the Company’s Chief Executive Officer and President since January 1, 2015 and as a member of the Company’s
Board of Directors since April 1, 2015;

 

WHEREAS, Grillo
now desires to voluntarily resign as an officer and director and separate from the Company and provide for the orderly transition
of responsibilities;

 

WHEREAS, in connection
with Grillo’s separation from the Company, the Company has agreed to make certain payments, in cash and shares of the Company’s
common stock, to Grillo in consideration of the terms set forth herein; and

 

WHEREAS, the Company
also desires to engage Grillo, as an independent contractor, to render consulting services to the Company, and Grillo desires to
provide such consulting services to the Company, following Grillo’s separation from the Company on the terms and conditions
set forth herein.

 

NOW, THEREFORE,
for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

 

1.               
Resignation and Separation from the Company.
Grillo hereby resigns as the Chief Executive Officer and President of the Company and as a member of the Board of Directors of
the Company (the “Board”), effective as of the first day of employment of the Company’s successor Chief
Executive Officer (the “Separation Date”), which as of the Effective Date is expected to be Joseph Burnett in
November 2017. Grillo and the Company agree that Grillo’s employment with the Company and that certain Employment Agreement,
dated as of September 9, 2014, by and between Grillo and the Company (the “Employment Agreement”), shall terminate
on the Separation Date, and that the provisions included in this Agreement shall constitute the entire agreement existing between
Grillo and the Company and that this Agreement shall supersede all prior agreements between Grillo and the Company concerning the
subject matter hereof as of the Separation Date. Grillo understands and agrees that he will not receive, nor be entitled to, any
additional salary or other pay subsequent to the Separation Date, except as set forth specifically in the Agreement terms described
herein. Notwithstanding the foregoing or any other provision to the contrary contained herein, that certain Non-Competition Agreement
and that certain Non-Disclosure and Proprietary Rights Agreement, each dated as of September 9, 2014, by and between Grillo and
the Company (collectively, the “Restrictive Agreements”), and all terms, conditions and provisions contained
therein, shall remain in full force and effect and continue to apply to Grillo in accordance with their terms. Upon any such breach,
all payments pursuant to Section 3 of this Agreement in connection with Grillo’s separation from the Company shall
immediately cease, or if already paid, shall be recoverable in full by the Company. 

2.               
Consulting Services. Following the Separation
Date, and provided that Grillo execute and not revoke the Release described in Section 4 of this Agreement, Grillo will
provide certain transition and consulting services to the Company, as more specifically described and pursuant to the terms and
conditions set forth below (the “Consulting Services”). Grillo shall devote such time, energy and skill as

    

    

    

may
be necessary to diligently perform the Consulting Services, and Grillo shall timely prepare and forward to the Company all reports,
accountings or other deliverables related to the Consulting Services as may be reasonably requested by the Company.

(a)             
For the period commencing on the Separation Date and ending sixty (60) days after the Separation
Date (the “Initial Transition Period”), Grillo shall provide full-time Consulting Services to the Company, which
shall include, without limitation, (i) working with the new Chief Executive Officer and other senior executives of the Company
and providing assistance to transition Grillo’s job functions and responsibilities and, in connection therewith, to execute
and deliver any documents, certificates, agreements, or instruments which are necessary to effect such transition, and (ii) providing
any other assistance as may reasonably be requested by the Company during the Initial Transition Period.

(b)            
Following the Initial Transition Period, Grillo shall continue to provide Consulting Services
to the Company as reasonably requested by the Company and otherwise agreed to by the parties from time to time, unless and until
either party elects to terminate the consulting relationship between the parties as provided herein by providing five (5) days’
written notice of termination to the other party. 

3.               
Payments and Other Benefits. 

(a)             
In exchange for and in consideration of all of the promises and covenants contained in this
Agreement (including, without limitation and contingent upon Grillo’s execution and delivery on the Separation Date of the
Release as more specifically described and defined in Section 4 of this Agreement, and further provided that Grillo not
revoke such Release), the Company agrees to provide Grillo with the following: 

 

(i)              
Grillo’s annual bonus, based on his and the Company’s performance for the fiscal
year ending December 31, 2017, determined in accordance with the applicable policies and procedures set forth in Grillo’s
Employment Agreement and based on the terms and conditions established by the Compensation Committee of the Board, which shall
be paid to Grillo, in cash, on or prior to March 15, 2018;

 

(ii)            
87,500 unregistered shares of the Company’s common stock, par value $0.01 per share,
issued by the Company to Grillo as of the Separation Date; 

 

(iii)          
A lump sum payment of Fifteen Thousand Dollars ($15,000) within ten (10) business days following
the Separation Date;

 

(iv)           
Extension of the option exercise period of all stock options previously granted to Grillo
such that the option exercise period is coterminous with the term of the option award; and

 

(v)            
The Company agrees that Grillo may keep his laptop computer.

 

(b)            
For the Consulting Services provided to the Company during the Initial Transition Period pursuant
to Section 2(a) of this Agreement, the Company shall pay Grillo at a rate of Thirty Thousand Dollars ($30,000.00) per month,
in arrears.

 

    

    

    

(c)             
For the Consulting Services requested by and provided to the Company following the Initial
Transition Period pursuant to Section 2(b) of this Agreement (and prior to the any termination of the consulting relationship
by Grillo or the Company), the Company shall pay Grillo at the rate of One Hundred Seventy Five Dollars ($175.00) per hour worked
with a maximum daily rate of One Thousand Four Hundred Dollars ($1,400.00). Notwithstanding the foregoing, for travel time, the
Company shall pay Grillo at the rate of Fifty Dollars ($50.00) per hour, with a maximum daily travel rate of Four Hundred Dollars
($400.00). For days that include both consulting and travel hours, the aggregate daily rate will be capped at One Thousand Four
Hundred Dollars ($1,400.00). Grillo will submit an invoice to the Company no later than the tenth (10th) day of each month that
sets forth, in reasonable detail, a description of the Consulting Services performed by Grillo during the previous month and the
amount of time Grillo spent providing such Consulting Services.

 

The Company’s obligations
to provide any payments or other benefits pursuant to this Section 3 are expressly conditioned on Grillo’s continued
compliance with all of the provisions of this Agreement.

 

4.               
Release. In exchange for and in consideration
of the separation payments and other benefits set forth in Section 3, Grillo hereby agrees to execute and deliver a general
release and waiver, in the form attached hereto as Exhibit A (the “Release”), to the Company on the Separation
Date. Grillo understands that he shall not be entitled to receive, and the Company shall not be obligated to provide, any payments
or other benefits set forth in Section 3 of this Agreement unless and until Grillo’s execution and delivery of the
Release as contemplated hereby has been accomplished. Grillo also acknowledges that he is being provided with at least twenty-one
(21) days to consider executing the Release. 

5.               
Expenses. The Company shall reimburse Grillo
for reasonable travel and lodging expenses incurred by Grillo in providing the Consulting Services described in Section 2,
provided that any travel must be approved by the Company in advance. The Company will not be responsible for any out-of-pocket
expenses incurred by Grillo in connection with the performance of Consulting Services under this Agreement unless such expenses
are agreed to in advance by the Company in writing. In any event, (a) the Company’s obligation to reimburse expenses pursuant
to this Section 5 is subject to Grillo’s presentation to the Company of a voucher or other documentation reasonably
satisfactory to the Company indicating the amount and purpose of the expenses incurred by Grillo, and (b) all expenses for which
Grillo requests reimbursement must be consistent with all applicable laws, rules and regulations as well as applicable the Company
policies.

6.               
Section 409(a). Pursuant to Section 409A of
the Internal Revenue Code of 1986, as amended (the “Code”) and Treas. Reg. §1.409A-1(n) promulgated thereunder,
the parties agree that as of the Separation Date, Grillo’s termination of employment is within the meaning set forth in Treas.
Reg. §1.409A-1(n) and all payments under this Agreement are intended to satisfy the “short-term deferral” exemption
under Treas. Reg. §1.409- 1(b)(4) and/or the “separation pay” exemption under Treas. Reg. §1.409-1(b)(9)
such that no payment hereunder shall be deemed “deferred compensation” within the meaning of Code Section 409A. 

7.               
Company Property; Confidential Information.

(a)             
Grillo shall deliver to the Company all documents, records, or other property of any nature
belonging to the Company in his custody or control on or promptly following the Separation Date, except as permitted by the Company
in connection with Consulting Services to be provided by Grillo after the Separation Date.

(b)            
In connection with the performance of Consulting Services, Grillo may receive information,
analyses, compilations, plans, designs, concepts, devices, research, studies and other materials relating to the Company’s
existing or potential business that are not generally available to the public (“Confidential Information”).
Without the Company’s prior written consent (which consent may be

    

    

    

withheld in the Company’s sole and absolute discretion),
Grillo will not (a) in any way disclose any of the Confidential Information to any third party, or (b) in any way use any of the
Confidential Information other than in the performance of the Consulting Services for the Company’s exclusive benefit. Without
in any way limiting the generality of the foregoing, in no event may Grillo include any Confidential Information in any application
for patent or other proprietary protection filed by or on behalf of Grillo in any country or jurisdiction. Grillo will take all
reasonable steps to safeguard the Confidential Information in order to prevent unauthorized disclosure or use thereof. All Confidential
Information coming into Grillo’s possession, regardless of the form, will remain the Company’s exclusive property.
Grillo will return to the Company all the Company property obtained upon any termination of such consulting relationship in accordance
with Section 2(b) of this Agreement.

(c)             
Notwithstanding anything in this Agreement to the contrary, nothing in this Agreement or this
Section 7 shall prohibit Grillo from cooperating with a government investigation or court order or from making a good-faith, truthful
report, or from providing documents or other information, to a government agency with oversight responsibility of the Company.

8.               
Developed Works. 

(a)       Grillo
will promptly disclose to the Company, in confidence and (if requested by the Company) in writing, any discoveries, inventions,
data, information, procedures, conclusions and other results conceived, created, developed, made or prepared by Grillo in connection
with or as a result of the performance of his Consulting Services or otherwise based on any Confidential Information received by
Grillo (“Developed Works”). The Company will be the sole owner of all Developed Works and all intellectual property
rights with respect thereto throughout the world. Grillo hereby irrevocably assigns to the Company all right, title and interest
of Grillo in and to any and all Developed Works and all intellectual property rights with respect thereto, whether or not patentable,
copyrightable or protectable as trade secrets. Grillo acknowledges that any Developed Work which is an original work of authorship
and which is copyrightable is a “work made for hire,” as that term is defined in the United States Copyright Act. In
addition to the foregoing assignment of Developed Works (and all intellectual property rights with respect thereto) to the Company,
Grillo hereby irrevocably assigns to the Company any and all “moral rights” that Grillo may have in or with respect
to any Developed Work, and Grillo forever waives and agrees not to assert any and all “moral rights” he may have in
or with respect to any Developed Work. All Developed Works will constitute Confidential Information subject to the provisions of
Section 7(b) above.

 

(b)       Grillo
agrees to assist the Company in obtaining and, from time to time, enforcing United States and foreign intellectual property rights
relating to Developed Works assigned hereunder to the Company. To that end, Grillo will execute, verify and deliver such documents
and perform such other acts as the Company may reasonably request for use in applying for, obtaining, perfecting, evidencing, sustaining
and enforcing such intellectual property rights and the assignment thereof. In addition, Grillo will execute, verify and deliver
assignments of such intellectual property rights to the Company or its designee.

 

9.               
Grillo Representations and Covenants. As of
the Effective Date, Grillo represents, warrants and, until the consulting relationship between Grillo and Company has been terminated
in accordance with Section 2(b) of this Agreement, covenants to the Company the following:

(a)             
Grillo is hereby advised, and Grillo acknowledges that he has been so advised, to consult
with an attorney of Grillo’s choice before signing this Agreement and the Release required to be executed on the Separation
Date, and Grillo acknowledges that he is signing this Agreement after having the opportunity to consult with an attorney and to
consider the terms of this Agreement (as well as the

    

    

    

Release required to be executed in connection herewith as of the Separation
Date); that Grillo has carefully read this Agreement in its entirety; that Grillo has had an adequate opportunity to consider it;
that Grillo understands its terms; that Grillo voluntarily assents to all the terms and conditions contained herein; that Grillo
is signing it voluntarily and of Grillo’s own free will, and that Grillo is not suffering from any disability or condition
that would render Grillo unable to enter into this Agreement;

 

(b)            
Grillo will not make any statements, written or verbal, that are derogatory or disparaging
concerning the Company, or concerning any current or former directors, officers, or employees of the Company and will pay for any
reasonable attorney’s fees incurred by the Company in recovering any sum due from Grillo as a consequence of his breach of
this Agreement shall be paid by Grillo;

 

(c)             
Grillo’s execution and delivery of this Agreement, and Grillo’s performance under
this Agreement, do not and will not (i) breach or otherwise conflict with any obligations binding on Grillo or to which Grillo
is or becomes subject, or (ii) require the consent of any third party that has not already been obtained as of the Effective Date.

 

(d)            
Grillo has not entered into, and will not enter into, any agreement, either written or oral,
in conflict with this Agreement.

 

(e)             
Grillo does not have any relationship with a third party, including a competitor of the Company,
which would present a conflict of interest with Grillo’s performance of the Consulting Services, or which would prevent Grillo
from carrying out the provisions of this Agreement, and Grillo will not enter into any such relationship prior to the termination
of the consulting relationship between Grillo and the Company pursuant to Section 2(b) of this Agreement;

 

(f)             
Grillo will comply with all applicable laws, rules and regulations in connection with his
performance of the Consulting Services hereunder and will comply with all the Company policies otherwise applicable to employee
conduct, including, but not limited to, the Company’s Interactions with Healthcare Professionals Policy (which Grillo acknowledges
having received);

 

(g)            
Grillo will not publish, nor submit for publication, any confidential or proprietary work
resulting from the Consulting Services provided hereunder without the Company’s prior written consent;

 

(h)            
Grillo will not, without the prior written consent of the Company, take any action that reasonably
could result in any person other than the Company having a claim to an ownership interest in any Developed Works;

 

(i)              
Grillo will not include any confidential, trade secret or other proprietary information of
any third party in any information disclosed to the Company;

 

(j)              
Grillo is not currently, and has never been, (i) a person who has been debarred, excluded
or suspended from (A) participating in any federal health care program, (B) participating in any federal contracting by the U.S.
General Services Administration or (C) submitting or assisting in the submission of any abbreviated drug application with the U.S.
Food and Drug Administration (in either case, “Debarment” or “Debarred”, as applicable),
or (ii) an employee, partner, stockholder or member of a Debarred person;

 

    

    

    

(k)            
Grillo has never been criminally convicted or found civilly liable for violating any federal,
state or local law, including, without limitation, the federal health care program anti-kickback statute (42 U.S.C §1320a-7b),
but excluding any minor traffic offenses or other traffic misdemeanor citations; and

 

(l)              
Grillo is not currently, and has never been, designated as a “Specially Designated National”
or “Blocked Person” by the Office of Foreign Asset Control of the U.S. Department of the Treasury.

 

10.            
Required Notices. Grillo will immediately
provide written notice to the Company if:

(a) Grillo becomes
a Debarred person or receives notice of action or threat of action with respect to his Debarment;

 

(b) Grillo is criminally
convicted or found civilly liable for violating any federal, state or local law, including, without limitation, the federal health
care program anti-kickback statute (42 U.S.C §1320a-7b) ), but excluding any minor traffic offenses or other traffic misdemeanor
citations; or

 

(c) Grillo becomes
designated as a “Specially Designated National” or “Blocked Person” by the Office of Foreign Asset Control
of the U.S. Department of the Treasury.

 

11.            
Independent Contractor. With respect to the
performance of the Consulting Services as contemplated by this Agreement, Grillo will be an independent contractor of the Company.
Grillo will not be an agent, employee or representative of the Company and nothing herein should be construed to constitute Grillo
as such. Grillo will not, under any circumstances, look to the Company as his employer, or as a partner, agent or principal, and
Grillo will have no right, power or authority to create any obligation, express or implied, on behalf of the Company. 

(a)  As an
independent contractor, Grillo will not be entitled to any benefits accorded to the Company’s employees (including, without
limitation, workers’ compensation, health insurance, disability insurance, vacation or sick pay), and the Company will not
be responsible for withholding from the compensation payable to Grillo any amounts for federal, state or local income taxes, social
security or state disability or unemployment insurance.

 

(b)  Grillo
will have the entire responsibility to discharge any and all of his obligations relating to taxes, unemployment compensation or
insurance, social security, workers’ compensation, disability pensions and tax withholdings (the “Tax Obligations”).
Grillo hereby agrees to indemnify the Company and hold the Company harmless for any and all Losses incurred or suffered by the
Company which arise out of Grillo’s failure to properly discharge his Tax Obligations.

 

12.            
Entire Agreement. This Agreement constitutes
the entire agreement between the parties with respect to the subject matter hereof and will supersede all previous negotiations,
commitments, and writings with respect to such subject matter, other than the Restrictive Agreements.

13.            
Amendment. No amendment, modification or supplement
of any provision of this Agreement will be valid or effective unless made in writing and signed by each party.

14.            
Assignment. This Agreement will be binding
upon and will inure to the benefit of the Company and Grillo and their respective successors and assigns; provided, however,
that Grillo may not assign this Agreement or delegate any duties and obligations hereunder.

    

    

    

15.            
Notices. Any notice required under this Agreement
must be in writing, must be addressed as provided below and will be deemed delivered (a) three business days after deposit in the
United States mail, postage prepaid and registered or certified, return receipt requested, (b) one business day after sent by nationally
recognized overnight receipted courier service with next day delivery specified, or (c) when actually received by the party to
whom such notice is required to be given, if such notice is delivered via electronic mail or any other method not identified in
the preceding clauses (a) and (b): 

If to the Company, the Company’s
address as set forth on the signature page of this Agreement;

 

If to Grillo, Grillo’s
address as set forth on the signature page of this Agreement;

 

and in any case at such other address as a
party may specify by written notice in accordance with this section. All periods of notice will be measured from the date of deemed
delivery as provided in this section.

 

16.            
Governing Law; Severability. This Agreement
will be governed, construed, and interpreted in all respects in accordance with the laws of the State of California without regard
to provisions regarding the conflict of laws. Whenever possible, each provision of this Agreement will be interpreted in a manner
to be effective, valid and enforceable. If, however, any provision of this Agreement is held to be illegal, invalid or unenforceable
under any present or future law, then such provision will be ineffective only to the extent of such prohibition or invalidity,
without invalidating or affecting in any manner whatsoever the remainder of such provision or the remaining provisions of this
Agreement. Furthermore, there will be added automatically as a part of this Agreement a provision as similar in terms to such illegal,
invalid, or unenforceable provision as may be possible and still have such similar provision be construed and enforced as legal,
valid, and enforceable. 

17.            
Descriptive Headings. The descriptive headings
of this Agreement are for convenience only and will be of no force or effect in construing or interpreting any of the provisions
of this Agreement.

18.            
Waiver of Compliance. The failure of either
party to comply with any obligation, covenant, agreement or condition under this Agreement may be waived by the party entitled
to the benefit thereof only by a written instrument signed by the party on granting such waiver, but such waiver or failure to
insist upon strict compliance with such obligation, covenant, agreement or condition will not operate as a waiver of, or estoppel
with respect to, any subsequent or other failure.

19.            
Counterparts. This Agreement may be executed
in any number of counterparts, each of which need not contain the signature of more than one party but all such counterparts taken
together will constitute one and the same agreement. In the event that any signature is delivered by facsimile transmission, or
by e-mail delivery of a “.pdf” format data file, such signature will create a valid and binding obligation of the party
executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf”
signature page was an original thereof. 

20.            
Construction. All plural nouns and pronouns
will be deemed to include the singular case thereof where the context requires, and vice versa. All pronouns will be gender neutral
unless the context otherwise requires. Any reference to any federal, state, local, or foreign statute or law will be deemed also
to refer to all rules and regulations promulgated thereunder, unless the context otherwise requires. The word “including”
will mean including without limitation.

 

[Signature page and Exhibit to Follow.]

 

    	 

    	 

    

IN WITNESS WHEREOF,
the parties hereto have executed this Agreement as of the Effective Date.

 

 

	COMPANY:
	 	 
	 	 
	MRI INTERVENTIONS, INC.
	 	 
	 	 
	By:	/s/ Harold A. Hurwitz
	Name:	Harold A. Hurwitz
	Title:	Chief Financial Officer
	 	 

	 	Address for Notice:
	 	MRI Interventions, Inc.
	 	5 Musick
	 	Irvine, CA 92618
	 	Attention: Chief Financial Officer
	 	Email: hhurwitz@mriinterventions.com
	 	 
	 	 
	 	 
	 	GRILLO:
	 	 

	 	/s/ Francis P. Grillo
	 	Francis P. Grillo
	 	 
	 	 
	 	Address for Notice:
	 	Francis P. Grillo
	 	1181 Lammy Place
	 	Los Altos, CA 94024
	 	Email: grillo_f@comcast.net

 

 

    	 

    	 

    

EXHIBIT A

 

RELEASE

 

 

See attached.

 

 

 

 

    	 

    	 

    

GENERAL RELEASE OF ALL CLAIMS

THIS GENERAL
RELEASE OF ALL CLAIMS (this “Release”) is made and entered into by and between FRANCIS P. GRILLO
(“Grillo”) and MRI INTERVENTIONS, INC., a Delaware corporation (the “Company”).

RECITALS

WHEREAS,
the Company and Grillo are parties to that certain Separation, Transition and Consulting Agreement, dated as of October 6, 2017
(the “Separation Agreement”);

WHEREAS,
in consideration of the agreements and covenants made by the Company in the Separation Agreement and as a condition to Grillo’s
receipt of the payments and other benefits provided in Section 3 of the Separation Agreement (the “Separation Benefits”),
Grillo has agreed to execute and deliver this Release in accordance with Section 4 of the Separation Agreement; and

WHEREAS,
in consideration of the agreements and covenants made by Grillo in the Separation Agreement and the execution and delivery of this
Release by Grillo, the Company has agreed to execute and deliver this Release.

NOW, THEREFORE,
in consideration of the foregoing Recitals, the mutual covenants and agreements and the terms and conditions set forth herein and
other valuable consideration, the parties agree as follows:

1.               
Compensation Through Separation Date. On the
Separation Date, Grillo was paid all unpaid base salary, accrued vacation and unpaid bonuses earned (if any), less state and federal
taxes and other required withholding, for the period from the last regular pay day through the Separation Date (the “Final
Wages Payment”). Grillo also acknowledges he has been paid for all business expenses in accordance with the Company’s
procedures for business expense reimbursement. Grillo acknowledges receipt of the Final Wages Payment and the expense reimbursement
payment, and agrees that the Company has paid to him all salary, accrued vacation, bonuses, benefits, expense reimbursement, and
any other consideration owed to him at any time and for any reason through the Separation Date. Grillo represents and agrees that
the Company owes no further sums to Grillo, other than the Separation Benefits the Company has agreed to provide pursuant to the
terms and subject to the conditions set forth in the Separation Agreement. 

2.               
Effective Date. The Effective Date of this
Release shall be the eighth (8th) day after Grillo’s dated execution of this Release, provided that Grillo has
not revoked this Release pursuant to Paragraph 11. However, this Release shall not apply to any claims that might arise
after the date Grillo executes the Release.

3.               
Return of Company Property. Grillo understands
that, except as otherwise provided by this Paragraph 3, as of the Separation Date, he was required to return to the Company,
and Grillo represents that he has returned to the Company, all tangible and intangible property and information belonging to the
Company that is within his possession or subject to his control, including but not limited to any equipment, supplies, business
cards, credit cards, and office machines, and also including any electronic or tangible documents or files relating to the Company,
except for such personnel and compensation records provided to Grillo during the course of his employment and as otherwise permitted
by the Company in connection with transition and consulting services contemplated to be provided by Grillo under the Separation
Agreement after the Separation Date. 

    

    

    

4.               
Complete Release of Claims by Grillo and Company.

A.             
In consideration for this Release, and to the maximum extent permitted by law, Grillo, for
himself, and his heirs, assigns, executors, administrators, agents and successors (collectively, “Grillo’s Affiliates”)
hereby fully releases and forever discharges the Company and each of its predecessors, successors, assigns, employees, officers,
directors, shareholders, agents, attorneys, subsidiaries, parent companies, divisions or affiliated corporations or organizations,
whether previously or hereafter affiliated in any manner (collectively, “Released Parties”), from any and all
claims, demands, actions, causes of action, obligations, damages, attorneys’ fees, costs, expenses, and liabilities of any
nature whatsoever, whether or not now known, suspected or claimed (the “Claims”) that in anyway arise from,
grow out of, or are related to Grillo’s employment with the Company, Grillo’s termination of employment with the Company,
or events that occurred before the date Grillo executes this Agreement. In giving this release, Grillo waives and releases any
and all rights to employment or re-employment with the Company or its subsidiaries. 

B.              
Without limiting the generality of the foregoing, Grillo understands and agrees that the release
provisions of this Paragraph 4 apply to any Claims that Grillo or the Grillo’s Affiliates now have, or may ever have
had, against the Company or any of the other Released Parties by reason of any act or omission concerning any matter, cause or
thing occurring on or before the date Grillo signs this Release that arise out of or are in any manner related to Grillo’s
employment with the Company, its subsidiaries or with any of the other Released Parties, as well as the separation of that employment,
including without limitation any Claims Grillo or Grillo’s Affiliates may have under any federal or state employment discrimination
laws, including the California Fair Employment and Housing Act; the California Family Rights Act; the Family and Medical Leave
Act; Title VII of the Civil Rights Act of 1964; the federal Age Discrimination in Employment Act, as amended; the Americans With
Disabilities Act; the National Labor Relations Act; the Equal Pay Act; the Employee Retirement Income Security Act of 1974; as
well as all Claims arising out of or related to violations of the California Government Code; the California Business & Professions
Code, including Business & Professions Code Section 17200, et seq.; breach of contract; fraud; misrepresentation; common counts;
unfair competition; unfair business practices; negligence; defamation; infliction of emotional distress; invasion of privacy; assault;
battery; false imprisonment; wrongful termination; and any other state or federal law, rule, or regulation. 

C.              
Grillo acknowledges and represents that he did not suffer any work-related injuries while
working for the Company. Grillo represents that he has no intention of filing any claim for workers’ compensation benefits
of any type against the Company.

5.               
Older Workers Benefit Protection Act. This
Release is subject to the terms of the Older Workers Benefit Protection Act of 1990 (the “OWBPA”). The OWBPA
provides that an individual cannot waive a right or claim under the Age Discrimination in Employment Act (“ADEA”)
unless the waiver is knowing and voluntary. Pursuant to the terms of the OWBPA, Grillo acknowledges and agrees that he has executed
this Release voluntarily, and with full knowledge of its consequences. In addition, Grillo hereby acknowledges and agrees that:
(a) this Release has been written in a manner that is calculated to be understood, and is understood, by Grillo; (b) the provision
of this Release apply to rights and claims that Grillo may have under the ADEA, including the right to file a lawsuit against the
Released Parties for age discrimination; (c) the provisions of this Release do not apply to any rights or claims that Grillo may
have under the ADEA that arise after the date Grillo executes this Release; (d) the

    

    

    

Company does not have a preexisting duty to
pay compensation identified in the Separation Agreement and this Release; and (e) Grillo has been advised in writing to consult
with an attorney regarding the terms and conditions of this Release. Upon consultation with Grillo’s attorney, or Grillo’s
decision not to consult with an attorney, Grillo agrees, covenants and represents that the termination of Grillo’s employment
shall not for any purpose be deemed to have resulted from an “exit incentive program” or “any other termination
program offered to a group or class of employees,” as those phrases are used in the OWBPA and its implementing regulations.

6.               
General Nature of Release; Claims Not Released.
The release by Grillo set forth above in Paragraph 4 of this Release is a general release of all claims, demands, causes
of action, obligations, damages, and liabilities of any nature whatsoever that are described in the Release and is intended to
encompass all known and unknown, foreseen and unforeseen claims that Grillo may have against the Released Parties, or any of them,
except for (a) any claims that may arise from the terms of this Release, (b) any claims which may not be released as a matter of
law, (c) any claims under the Indemnification Agreement entered into by Grillo and the Company in connection with Grillo’s
service as a director and officer of the Company, (d) any claims for indemnification and/or reimbursement of expenses by the Company
with respect to which Grillo may be eligible by reason of Grillo’s indemnification rights under any applicable statute or
provision of the Company’s charter documents, (e) any claims for coverage under any D&O or other similar insurance policy
or (f) any claims that may arise after the date this Release is executed by Grillo. It is further understood by the parties that
nothing in this Release shall affect any rights Grillo may have under any Pension Plan and/or Savings Plan (i.e., 401(k) plan)
provided by the Company as of the Separation Date, such items to be governed exclusively by the terms of the applicable plan documents.

7.               
Covenant Not to Sue. Grillo covenants and
agrees never to commence, aid in any way, prosecute or cause to be commenced or prosecuted any action or other proceeding based
upon any Claims which are the subject of this Release; provided however, that Grillo does not relinquish any protected rights to
file a charge, testify, assist or participate in any manner in an investigation, hearing or proceeding conducted by the Equal Employment
Opportunity Commission, the Office of Federal Contract Compliance, the California Department of Fair Employment and Housing, or
any similar state human rights agency. However, Grillo agrees that should Grill obtain damages, or should the EEOC or any other
third party obtain damages or other relief on Grillo’s behalf arising out of a claim concerning Grillo’s employment
with the Company, Grillo will completely waive and forego the receipt of all such damages or other relief. Notwithstanding anything
in this Paragraph 7 to the contrary, this covenant not to sue shall not prohibit Grillo from filing, pursuant to 29 CFR §
1625.23, a lawsuit to challenge the enforceability of the Release with respect to a claim under the ADEA.

8.               
Release of Section 1542 Rights. Grillo expressly
waives and relinquishes all rights and benefits he may have under Section 1542 of the California Civil Code. Section 1542
is intended to protect against an inadvertent release of unknown or unsuspected claims that would be material to this Release.
This Paragraph 8 provides that Grillo also is releasing any such unknown or unsuspected claims. Section 1542 reads as follows:

“Section
1542. [General Release; extent.] A general release does not extend to claims which the creditor does not know or suspect to exist
in his or her favor at the time of executing the release, which if known by him or her must have materially affected his or her
settlement with the debtor.”

    

    

    

9.               
Non-Admission of Liability. Grillo and the
Company acknowledge and agree that this Release shall not in any way be construed as an admission by any of the Released Parties
of any wrongful act against, or any liability to, Grillo or any other person.

10.            
Protection of Trade Secrets. Grillo agrees
to keep in strict confidence at all times, and that he will not at any time, either directly or indirectly, make known, reveal,
make available or use, any Trade Secrets as defined herein, which Grillo obtained during or by virtue of his employment with the
Company. The parties agree that “Trade Secrets” as used herein means all confidential information which (i) has been
the subject of reasonable efforts by the Company to maintain as secret and confidential, (ii) pertains in any manner to the business
of the Company, including proprietary information entrusted to the Company in confidence by its customers or suppliers (except
to the extent such information is generally known or made available to the public or to the Company’s competitors through
lawful means), and (iii) has independent economic value by virtue of not being generally known to other persons who could obtain
economic value from its disclosure or use. Grillo acknowledges that all Trade Secrets, as well as all other confidential information
or data of the Company, are and remain the exclusive property of the Company (or, in the case of proprietary information belonging
to a customer or supplier who has entrusted it to the Company, the exclusive property of that person or entity). Grillo and the
Company further agree that the following information constitutes a non-exclusive listing of Trade Secrets coming within the terms
of this Release: the customer contacts and business requirements of the Company’s current customers with respect to the Company’s
products; the supplier contacts and business requirements of the Company’s suppliers with respect to the Company’s
products; the specific nature and amount of business conducted by the Company with its customers and suppliers; the product specifications
required by the Company’s customers or required by the Company of its suppliers; customer and supplier pricing information
and discount schedules with respect to the Company’s products or supplies; and the Company’s business plans and strategies
for acquiring new products, customers, or manufacturing sources or otherwise expanding or improving its product offerings to customers.
Grillo further agrees that he shall not directly or indirectly solicit business from or with respect to any customers or suppliers
of the Company through the use of any Trade Secrets. 

11.            
Twenty-One Day Consideration Period. This
Release was given to Grillo on October 6, 2017 (the “Delivery Date”). Accordingly, Grillo acknowledges that,
commencing on the Delivery Date, he is entitled to take up to twenty-one (21) calendar days to consider whether to accept this
Release, and that if he signs this Release before expiration of the 21-day period, he has done so voluntarily. 

12.            
Seven-Day Revocation Period. After signing
this Release, Grillo shall have a period of seven (7) calendar days to revoke the Agreement by providing the Company with written
notice of his revocation. To be effective, such revocation must be in writing, must specifically revoke this Release, and must
be received by the Company prior to the eighth calendar day following Grillo’s execution of this Release. This Release shall
become effective, enforceable, and irrevocable on the eighth (8th) calendar day following Grillo’s execution of
this Release. Any revocation of this Release, however, shall not affect the finality of the separation of Grillo’s employment
with the Company and its subsidiaries on the Separation Date (as defined in the Separation Agreement).

13.            
Acknowledgment of Being Advised to Consult Legal Counsel.
This Release is an important legal document. Grillo acknowledges that the Company has advised him in writing to consult with an
attorney of his choice prior to signing this Release, and that he has had the opportunity to consult with an attorney to the extent
he so desires.

    

    

    

14.            
Confidentiality. As a material inducement
to the Company to enter into this Release, Grillo promises and agrees to maintain confidentiality regarding this Release to the
extent permitted by applicable law, except to the extent the Company publicly discloses its terms in accordance with public company
disclosure requirements. Therefore, except to the extent of any public disclosure by the Company, Grillo promises and covenants
not to disclose, publicize, or cause to be publicized any of the terms and conditions of this Release except to his immediate family,
and to his attorney or accountant to the extent reasonably necessary to obtain professional advice with respect to the parties’
rights and obligations as stated herein, to the extent necessary to enforce this Release, or otherwise as permitted by law. Grillo
further promises and covenants to use his best efforts to prevent any further disclosure of this Release by any such persons to
whom he does make disclosure.

15.            
Ambiguities. Grillo and the Company agree
that the general rule that ambiguities shall be construed against the drafting party shall not apply to any interpretation of this
Release.

16.            
Interpretation. Whenever possible, each provision
of this Release shall be interpreted in such a manner as to be valid and effective under applicable law. If any provision of this
Release shall be unlawful, void or for any reason unenforceable, it shall be deemed separable from, and shall in no way affect
the validity or enforceability of, the remaining provisions of this Release, and the rights and obligations of the parties shall
be enforced to the fullest extent possible. All captions are for convenience of reference only and shall be disregarded in interpreting
this Release.

17.            
Entire Agreement. Grillo acknowledges that
he is not relying, and has not relied, on any representation or statement by the Company with regard to the subject matter or terms
of this Release, except to the extent set forth fully in this Release. This Release constitutes the entire agreement between Grillo
and the Company with respect to the subject matter of this Release, and supersedes any and all other agreements, understandings
or discussions between Grillo and the Company with respect to the subject matter of this Release, other than the Separation Agreement.

18.            
Risk of New or Different Facts. Grillo acknowledges
that he may discover new information different from or inconsistent with facts he presently believes to be true, and expressly
agrees to assume the risk of such new or different information.

19.            
Modification. This Release cannot be modified
or terminated, except by a writing signed by the party against whom enforcement of the modification or termination is sought.

20.            
Voluntary Agreement. This Release in all respects
has been voluntarily and knowingly executed by the parties hereto. Grillo specifically represents that he has carefully read and
fully understands all of the provisions of this Release, and that he is voluntarily entering into this Release.

21.            
Execution in Counterparts. This Release may
be executed in any number of counterparts, each of which shall be deemed an original, but all of which shall constitute one and
the same instrument.

22.            
Governing Law. The validity and effect of
this Release shall be governed by and construed and enforced in accordance with the laws of the State of California, without giving
effect to conflicts of laws principles.

[Signature Page
Follows]

    	 

    	 

    

IN WITNESS WHEREOF,
the parties hereto have executed this General Release of All Claims and have initialed each page hereof (other than this signature
page), on the dates set forth below.

 

	 	 	 
	Dated: __________________________ , 2017	 	 
	 	 	Francis P. Grillo
	 	 	 
	 	 	 
	 	 	 
	 	 	MRI INTERVENTIONS, INC.
	 	 	 
	Dated: __________________________ , 2017	 	 
	 	 	By:
	 	 	Its:EXHIBIT 10.2

EMPLOYMENT AGREEMENT

 

THIS AGREEMENT (this
“Agreement”) is entered into as of this 6th day of October 2017 (the “Effective Date”),
by and between MRI INTERVENTIONS, INC., a Delaware corporation (the “Company”), and JOSEPH MICHAEL
BURNETT (the “Executive”).

 

WITNESSETH:

 

WHEREAS, the Company
desires to employ the Executive to serve as the Chief Executive Officer and President of the Company on the terms and conditions
set forth herein;

 

WHEREAS, the Company
and the Executive each deem it necessary and desirable to execute a written document setting forth the terms and conditions of
said relationship; and

 

WHEREAS, to the
extent this Agreement provides for any “deferred compensation” within the meaning of Section 409A of the Internal Revenue
Code of 1986, as amended (the “Code”), the Agreement will be administered in compliance with Section 409A of
the Code and the regulations promulgated thereunder.

 

NOW, THEREFORE,
in consideration of the premises and mutual obligations hereinafter set forth, the parties agree as follows:

1.        Definitions. For purposes of this Agreement, the following terms shall have the following
definitions:

 

“Accounting Firm” has
the meaning set forth in Section 11(b) of this Agreement.

 

“Affiliate”
has the same meaning ascribed to such term in Rule 12b-2 under the Exchange Act.

 

“Agreement”
has the meaning set forth in the preamble above.

 

“Annual Bonus”
has the meaning set forth in Section 4(b) of this Agreement.

 

“Award Agreement”
has the meaning set forth in Section 11(b) of this Agreement.

 

“Award Plans”
has the meaning set forth in Section 4(d) of this Agreement.

 

“Base Salary”
means the annual salary to be paid to the Executive as set forth in Section 4(a) of this Agreement.

 

“Benefit Plans”
has the meaning set forth in Section 4(e) of this Agreement.

 

“Board”
means the Board of Directors of the Company.

 

“Change
of Control” means the occurrence with respect to the Company of any of the following events: (i) a change in the ownership
of the Company; (ii) a change in the effective control of the Company; or (iii) a change in the ownership of a substantial portion
of the assets of the Company.

For purposes of
this definition, a change in the ownership of the Company occurs on the date on which any one person, or more than one person acting
as a group, acquires ownership of stock of the Company that, together with stock held by such person or group, constitutes more
than 50% of the total 

 

    		1	 

     

    

fair market value or total voting power of the stock of the Company. A change in the effective control of
the Company occurs on the date on which either (i) a person, or more than one person acting as a group, acquires ownership of stock
of the Company possessing 30% or more of the total voting power of the stock of the Company, taking into account all such stock
acquired during the 12-month period ending on the date of the most recent acquisition, or (ii) a majority of the members of the
Board is replaced during any 12-month period by directors whose appointment or election is not endorsed by a majority of the members
of such Board prior to the date of the appointment or election. A change in the ownership of a substantial portion of the assets
of the Company occurs on the date on which any one person, or more than one person acting as a group, other than a person or group
of persons that is related to the Company, acquires assets from the Company that have a total gross fair market value equal to
or more than 40% of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition
or acquisitions, taking into account all such assets acquired during the 12-month period ending on the date of the most recent
acquisition.

The determination
as to the occurrence of a Change of Control shall be based on objective facts and in accordance with the requirements of Section
409A of the Code.

“Change of Control
Termination” means (i) a Termination Without Cause or (ii) a Termination for Good Reason, in either case within two (2)
months prior to, on, or within one (1) year after, a Change of Control.

 

“Code”
has the meaning set forth in the recitals above.

 

“Company”
has the meaning set forth in the preamble above.

 

“Company Incentive
Plan” means, collectively, the Company’s current equity incentive plan, as such may be amended from time to time,
and any other equity incentive plan adopted by the Company from time to time.

 

“Company Shares”
means shares of common stock of the Company or any securities of a successor company which shall have replaced such common stock.

 

“Compensation
Committee” means the compensation committee of the Board.

 

“Confidentiality
Agreement” means that certain Non-Disclosure and Proprietary Rights Agreement between the Company and the Executive in
substantially the form attached hereto as Exhibit A.

 

“Effective Date”
has the meaning set forth in the preamble above.

 

“Exchange Act”
means the Securities Exchange Act of 1934, as amended.

 

“Excise Tax”
means the excise tax imposed by Section 4999 of the Code with respect to the Total Payments, together with any interest or penalties
with respect to such excise tax.

 

“Executive”
has the meaning set forth in the preamble above.

 

“Initial Signing
Bonus” has the meaning set forth in Section 4(c) of this Agreement.

 

“Net After-Tax
Benefit” means (i) the Total Payments, less (ii) the amount of all United States federal, state and local income and
employment taxes payable with respect to the Total Payments

 

    		2	 

     

    

(calculated at the maximum applicable marginal income tax rate for
the Executive under the Code), and less (iii) the amount of the Excise Tax imposed (based upon the rate for such year as set forth
in the Code at the time of the first payment of the foregoing).

 

“Non-Compete Agreement”
means that certain Non-Compete Agreement between the Company and the Executive in substantially the form attached hereto as Exhibit
B.

 

“Non-Qualified
Stock Option Agreement” means that certain Non-Qualified Stock Option Agreement between the Company and the Executive
in substantially the form attached hereto as Exhibit C.

 

“Option(s)”
means (i) any option issued to the Executive pursuant to a Company Incentive Plan, (ii) other than options described in the preceding
clause (i), any option issued to the Executive by the Company to purchase Company Shares, or (iii) any option granted under the
plan of any successor company that replaces or assumes the Company’s options.

 

“Permanent Disability”
means the Executive: (i) is unable to engage in any substantial gainful activity by reason of any medically determinable physical
or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than
twelve (12) months; or (ii) is, by reason of any medically determinable physical or mental impairment which can be expected to
result in death or can be expected to last for a continuous period of not less than twelve (12) months, receiving income replacement
benefits for a period of not less than three (3) months under an accident and health plan covering employees or directors of the
Company. Medical determination of Permanent Disability may be made by either the Social Security Administration or by the provider
of an accident or health plan covering employees or directors of the Company provided that the definition of “disability”
applied under such disability insurance program complies with the requirements of the preceding sentence. Upon the request of the
Company, the Executive must submit proof to the Company of the Social Security Administration’s or the provider’s determination.

 

“Relocation Period”
has the meaning set forth in Section 5(b) of this Agreement.

 

“Restricted Share
Award Agreement” means that certain Restricted Share Award Agreement between the Company and the Executive in substantially
the form attached hereto as Exhibit D.

 

“Restricted Stock”
means (i) any restricted Company Shares issued to the Executive pursuant to a Company Incentive Plan, (ii) other than restricted
Company Shares described in the preceding clause (i), any restricted Company Shares issued to the Executive by the Company, or
(iii) any restricted stock granted under the plan of any successor company that replaces or assumes the Company’s restricted
stock awards.

 

“Section 4999
Limit” has the meaning set forth in Section 11(a) of this Agreement.

 

“Specified Employee”
means a key employee (as defined in Section 416(i) of the Code without regard to paragraph 5 thereof) of the Company if any stock
of the Company is publicly traded on an established securities market or otherwise.

 

“Start Date”
has the meaning set forth in Section 3(a) of this Agreement.

 

“Term”
has the meaning assigned to it in Section 3(a) of this Agreement.

 

    		3	 

     

    

“Termination Date”
means the date on which the employment of the Executive is terminated, which date shall be (i) in the case of the Executive’s
death, the date of death, (ii) in the case of the Executive’s Permanent Disability, thirty (30) days after a Termination
Notice is given, provided the Executive does not return to the full-time performance of his duties within such thirty (30) day
period, (iii) in the case of a Termination Upon Expiration, the date upon which the Term expires, (iv) in the case of a Termination
With Cause, the date specified in the Termination Notice, or (v) in all other instances, the date specified as the Termination
Date in the Termination Notice, which date shall not be less than ten (10) days from the date the Termination Notice is given.

 

“Termination
for Good Reason” means the termination of the Executive’s employment with the Company by the Executive based on
any of the following circumstances, if, within the six (6) month period preceding the Executive’s termination, the Executive
notified the Company in writing of such circumstances within ninety (90) days of occurrence and the Company did not remedy such
circumstances within thirty (30) days thereafter:

(i)        a material demotion or diminution in the Executive’s authority, duties or responsibilities
without the Executive’s consent; or

(ii)       a relocation of the company such that the Executive’s commute is extended by more than
an additional 50 miles;

(iii)      any action or inaction that constitutes a material breach by the Company of this Agreement.

“Termination Notice”
means a written notice of termination of employment by the Executive or the Company.

 

“Termination of
Employment” means the termination of the Executive’s employment with the Company for reasons other than death or
Permanent Disability. Whether a Termination of Employment takes place is determined based on the facts and circumstances surrounding
the termination of the Executive’s employment and whether the Company and the Executive intended for the Executive to provide
significant services for the Company following such termination. A change in the Executive’s employment status will not be
considered a Termination of Employment if the Executive continues to provide services as an employee of the Company or in any other
capacity at an annual rate that is twenty percent (20%) or more of the services rendered, on average, during the immediately preceding
three full calendar years of employment (or, if employed less than three years, such lesser period).

 

“Termination Upon
Expiration” means the termination of the Executive’s employment upon the full expiration of the Term, including
the full expiration of any extension thereof, following: (i) the Company’s notice to the Executive of the Company’s
election to not extend the Term; or (ii) the Executive’s notice to the Company of the Executive’s election to not extend
the Term, in each case as provided in Section 3(a) of this Agreement.

 

“Termination With
Cause” means the termination of the Executive’s employment by the Company for any of the following reasons: (i)
the Executive’s gross negligence or willful misconduct in the performance of the Executive’s duties where such gross
negligence or willful misconduct has resulted or is likely to result in substantial and material damage to the Company; (ii) the
material violation by the Executive of any federal or state law or regulation or the Company’s compliance program in the
performance of the Executive’s duties; (iii) the Executive’s breach of the Non-Compete Agreement; (iv) the Executive’s
material breach of the Confidentiality Agreement; (v) the Executive’s commission of any act of fraud with respect to the
Company; (vi) the Executive’s conviction of, or the Executive’s entry of a

 

    		4	 

     

    

guilty plea or plea of nolo contendere with
respect to, a felony; or (vii) the Executive’s material failure to perform duties consistent with this Agreement or the Executive’s
position or to follow or comply with the reasonable directives of the Board or the Executive’s supervisor(s) (to the extent
not inconsistent with the terms of this Agreement), provided that (A) the Executive shall have received written notice within ninety
(90) days of the occurrence of such failure that specifically identifies the manner in which the Company believes that Executive
has engaged in such failure and (B) the Executive shall not have cured such failure within thirty (30) days following receipt of
such notice, provided further that such opportunity to cure a failure shall not apply if the Executive has received more than one
notice with respect to the same or similar conduct pursuant to this clause (vii) during any twelve (12) consecutive month period.

 

“Termination Without
Cause” means the termination of the Executive’s employment by the Company for any reason other than (i) Termination
With Cause, (ii) termination by the Company due to the Executive’s death or Permanent Disability, or (iii) Termination Upon
Expiration.

 

“Total Payments”
means the total payments or other benefits that the Executive becomes entitled to receive from the Company or an Affiliate thereof
in connection with a Change of Control that would constitute a “parachute payment” (within the meaning of Section 280G
of the Code), whether payable pursuant to the terms of this Agreement or any other plan, arrangement or agreement with the Company
or an Affiliate thereof.

 

“Voluntary Termination”
means the Executive’s voluntary termination of his employment hereunder for any reason, other than a Termination for Good
Reason. If the Executive gives a Termination Notice of Voluntary Termination and, prior to the Termination Date, the Executive
voluntarily refuses or fails to provide substantially all the services described in Section 2 hereof, the Voluntary
Termination shall be deemed to be effective as of the date on which the Executive so ceases to carry out his duties. Voluntary
refusal to perform services shall not include (i) taking vacation otherwise permitted in accordance with Section 4(g)
hereof, (ii) the Executive’s failure to perform services on account of his illness or the illness of a member of the Executive’s
immediate family, provided such illness is adequately substantiated at the reasonable request of the Company, or (iii) any
other absence from service permitted by applicable State or Federal law or with the written consent of the Board.

2.        Employment; Services. The Company shall employ the Executive, and the Executive agrees
to be so employed, in the capacity of the Chief Executive Officer and President as of the Start Date and through the Term as provided
in Section 3(a) of this Agreement. The Executive shall assume and discharge such duties and responsibilities as are
commensurate with the Executive’s position. The Executive shall be a full-time employee of the Company and shall exert his
best efforts and devote substantially all of his business time and attention to the Company’s affairs and the performance
of his duties hereunder.

3.        Term; Termination.

(a)        The term of the Executive’s employment under this Agreement (the “Term”)
shall be for three (3) years and shall commence as of November 7, 2017 (the “Start Date”). On the third anniversary
of the Start Date and each successive anniversary of the Start Date, the Term shall be extended for an additional one (1) year
period, unless one party gives notice to the other of such party’s election to not extend the Term, which notice must be
given no later than ninety (90) days prior to the end of the then-current Term. Notwithstanding the foregoing, employment during
the Term shall be subject to earlier termination in accordance with the terms of this Agreement.

 

    		5	 

     

    

(b)        Any purported termination of employment by the Executive or the Company, other than by reason
of the Executive’s death, shall be communicated by a Termination Notice. The Termination Notice shall indicate the specific
termination provision in this Agreement relied upon and, in the event of a Termination With Cause or a Termination for Good Reason,
set forth the facts and circumstances claimed to provide a basis for termination. 

4.        Compensation.

(a)        Base Salary. During the Term, the Company shall pay the Executive for his services
a “Base Salary” of Three Hundred Sixty Thousand Dollars ($360,000) per year, to be paid in accordance with customary
Company policies. The Base Salary shall be subject to increase or decrease according to policies and practices adopted by the Compensation
Committee or the Board, as the case may be; provided, however, that in no event (i) shall the Base Salary for any year be decreased
by more than ten percent (10%) from the immediately preceding year’s Base Salary, and (ii) shall the Base Salary be less
than Three Hundred Sixty Thousand Dollars ($360,000).

(b)        Annual Bonus. Starting with the Company’s fiscal year commencing on January 1,
2018, the Executive shall be eligible to receive an annual incentive bonus in an amount not to exceed forty percent (40%) of the
Executive’s Base Salary (an “Annual Bonus”), subject to the terms and conditions established by the Compensation
Committee in consultation with the Executive. The Compensation Committee shall determine in good faith the Executive’s entitlement
to an Annual Bonus based on the achievement or satisfaction of such terms, conditions and goals as soon as reasonably practicable
after the end of each calendar year. The Company shall pay the Annual Bonus, if any, to the Executive within ten (10) days after
the Compensation Committee makes such determination and in any event not later than March 15 of the year following the calendar
year in which the services upon which the Annual Bonus is based were performed; provided, however, that, notwithstanding
any provision of this Agreement to the contrary, the Company shall not be obligated to pay, and the Executive shall not be entitled
to receive, any such Annual Bonus unless the Executive remains employed by the Company on the date of payment.

(c)        Initial Signing Bonus. To induce the Executive to commence employment with the Company
as of the Start Date, the Company shall pay to the Executive an initial signing bonus of One Hundred Thousand Dollars ($100,000)
(the “Initial Signing Bonus”), which shall consist of two payments of Fifty Thousand Dollars ($50,000.00) each.
The first $50,000 payment shall be made within ten (10) business days of the Start Date. The second $50,000 payment shall be made
within ten (10) business days of the six-month anniversary of the Start Date; provided, however, that, notwithstanding
any provision of this Agreement to the contrary, the Company shall not be obligated to pay, and the Executive shall not be entitled
to receive, the second payment of the Initial Signing Bonus unless the Executive remains employed by the Company on the date of
such payment.

(d)        Inducement Grants. To induce the Executive to commence employment with the Company
as of the Start Date, the Company shall grant the Executive, effective as of the Start Date: (i) an Option on the terms and conditions
set forth in the Non-Qualified Stock Option Agreement; and (ii) Restricted Stock on the terms and conditions set forth in the Restricted
Share Award Agreement.

(e)        Award Plans. During the Term, the Executive shall generally be eligible to participate
in Company Incentive Plans and any other incentive compensation, profit participation or extra compensation plan that is adopted
by the Company and in which the Company’s executive officers generally participate (collectively, “Award Plans”),
according to the policies and practices adopted by the Compensation Committee or the Board, as the case may be.

 

    		6	 

     

    

(f)         Benefit Plans. During the Term, the Executive shall be entitled to participate in,
and to all rights and benefits provided by, the health, life, medical, dental, disability, insurance and welfare plans that are
maintained from time to time by the Company for the benefit of the Executive, the executives of the Company generally or for the
Company’s employees generally, provided that the Executive is eligible to participate in such plan under the eligibility
provisions thereof that are generally applicable to the participants thereof (collectively, “Benefit Plans”).

(g)         Vacation. The Executive shall be entitled each year to vacation time, during which
time his compensation shall be paid in full. The time allotted for such vacation shall be four (4) weeks, to be taken at such time
or times as shall be mutually convenient and consistent with his duties and obligations to the Company. Vacation accrues based
on the Executive’s anniversary date. Any unused vacation shall be subject to the Company’s policies regarding same,
as such may be amended from time to time.

(h)         Overall Qualification. Nothing in this Agreement shall be construed as preventing the
Company from modifying, suspending, discontinuing or terminating any of the Benefit Plans or Award Plans without notice or liability
to the Executive so long as (i) the modification, suspension, discontinuation or termination of any such plan is authorized by
and performed in accordance with the specific provisions of such plan and (ii) such modification, suspension, discontinuation or
termination is taken generally with respect to all similarly situated employees of the Company and does not single out or discriminate
against the Executive.

5.               
Expenses.

(a)         General. The Company recognizes that the Executive will have to incur certain out-of-pocket
expenses, including but not limited to travel expenses, related to his services and the Company’s business and the Company
agrees, to reimburse the Executive for all reasonable expenses necessarily incurred by him in the performance of his duties upon
presentation of documentation indicating the amount and business purposes of any such expenses; provided, that the Executive complies
with the Company’s policies and procedures regarding business expenses.

(b)         Relocation. During the period commencing on the Start Date and ending on the second
anniversary of the Start Date (the “Relocation Period”), the Executive shall be entitled to reimbursement for
reasonable relocation expenses up to Fifty Thousand Dollars ($50,000.00), in the aggregate. Notwithstanding the foregoing, in the
event the Executive ceases to be an employee of the Company (i) within 12 months of being reimbursed for relocation expenses per
above, the Company shall have the right to claw back (including, without limitation, retaining any payments owed to the Executive
hereunder for such purpose) and the Executive agrees to repay one hundred percent (100%) of the relocation expenses paid by the
Company pursuant to this Section 5(b); or (ii) in the event the Executive ceases to be an employee of the Company between 12 -
24 months of being reimbursed for relocation expenses per above, the Company shall have the right to claw back (including, without
limitation, retaining any payments owed to the Executive hereunder for such purpose) and the Executive agrees to repay fifty percent
(50%) of the relocation expenses paid by the Company pursuant to this Section 5(b), as applicable, within ten (10) business days
of the Executive’s Termination Date.

6.         Voluntary Termination; Termination With Cause. If the Executive shall cease being an
employee of the Company on account of the Executive’s Voluntary Termination or a Termination With Cause, the Executive shall
have no further rights against the Company hereunder after the Termination Date, except for the right to receive (i) any Base Salary
and bonus compensation earned but unpaid as of the Termination Date, (ii) accrued vacation and other vested benefits under the
Company’s Award and

 

    		7	 

     

    

Benefit Plans; and (iii) reimbursement of business expenses to which the Executive is entitled as of
the Termination Date pursuant to Section 5(a). In the event of a Voluntary Termination or a Termination With Cause,
the Executive shall continue to be subject to the Confidentiality Agreement and the Non-Compete Agreement. 

7.         Termination Upon Death or Permanent Disability.

(a)         Death. The Executive’s employment with the Company shall terminate automatically
upon the Executive’s death. Upon termination of employment due to the Executive’s death, the Executive’s estate
shall have no further rights against the Company hereunder after the Termination Date, except for the right to receive (i) any
Base Salary and bonus compensation earned but unpaid as of the Termination Date, plus (ii) any unreimbursed business expenses to
which the Executive is entitled as of the Termination Date pursuant to Section 5(a), plus (iii) the lump sum amount
of Eighteen Thousand Dollars ($18,000). In addition, the Executive’s estate shall be entitled to any vested benefits under
the Company’s Award Plans and Benefit Plans as of the Termination Date, in accordance with the terms of such plans.

(b)         Permanent Disability. In the event of the Executive’s Permanent Disability, the
Company may terminate the Executive’s employment with the Company if the Executive does not return to the full-time performance
of his duties within thirty (30) days after a Termination Notice is given. Upon termination of employment due to the Executive’s
Permanent Disability, the Executive shall have no further rights against the Company hereunder after the Termination Date, except
for the right to receive (i) any Base Salary and bonus compensation earned but unpaid as of the Termination Date, plus (ii) any
unreimbursed business expenses to which the Executive is entitled as of the Termination Date pursuant to Section 5(a),
plus (iii) the lump sum amount of Eighteen Thousand Dollars ($18,000). In addition, the Executive shall be entitled to any vested
benefits under the Company’s Award Plans and Benefit Plans as of the Termination Date, in accordance with the terms of such
plans. In the event of a termination of employment upon the Executive’s Permanent Disability, the Executive shall continue
to be subject to the Confidentiality Agreement and the Non-Compete Agreement.

(c)         Life Insurance. Upon the Company’s request, the Executive shall cooperate with
the Company in obtaining “key man” life insurance on the life of the Executive with death benefits payable to the Company.

8.         Termination Without Cause; Termination for Good Reason. The Company may terminate the
Executive’s employment for any reason, or no reason at all, at any time, and the Executive may effect a Termination for Good
Reason at any time; provided, that upon a Termination for Good Reason or a Termination Without Cause, except as otherwise provided
in Section 10 of this Agreement, the Company shall provide the compensation and benefits set forth in this Section 8.
The Executive may effect a Termination for Good Reason notwithstanding any incapacity due to physical or mental illness. In the
event of a Termination Without Cause or a Termination for Good Reason, the Executive shall continue to be subject to the Confidentiality
Agreement and the Non-Compete Agreement.

(a)         Base Salary, Annual Bonus, Benefit Plans and Award Plans. The Company shall pay to
the Executive, on the Termination Date, a lump sum amount which is equal to the sum of: (i) an amount equal to the Executive’s
Base Salary in effect on the Termination Date; plus (ii) an amount equal to the average annual cash bonus, if any, paid to the
Executive for the two (2) years preceding the year in which the Termination Date occurs; plus (iii) Eighteen Thousand Dollars ($18,000);
plus (iv) any Base Salary and bonus compensation earned but unpaid as of the Termination Date; plus (v) any unreimbursed business
expenses to which the Executive is entitled as of the Termination Date pursuant to Section 5(a).

 

    		8	 

     

    

The Company shall also
pay the Executive any amounts due to the Executive pursuant to the terms of any Award Plans and/or Benefit Plans in which the Executive
was a participant, in accordance with the terms of such plans. Notwithstanding the foregoing, if the Executive is a Specified Employee
and the total of the payments under this Section 8(a) exceeds the limit set forth in Treas. Reg. §1.409A-1(b)(9)(iii)(A)
(related to separation pay), then the amount in excess of such limit shall be delayed for six (6) months following the Termination
Date. The delayed amount shall be paid in a lump sum after the end of the six-month delay.

(b)         Options; Restricted Stock. Notwithstanding the terms of any award agreement heretofore
or hereafter granted to the Executive under any Award Plan, or any other agreement granting the Executive Options or Restricted
Stock (in each case, an “Award Agreement”), upon a Termination Without Cause or Termination for Good Reason,
(i) all Options and Restricted Stock granted to the Executive which do not constitute deferred compensation for Code Section 409A
purposes granted to the Executive shall become fully vested on the Termination Date and immediately prior to the time of termination,
and (ii) the Executive shall continue to have the right to exercise any such Options until the earlier to occur of (A) the three
(3) year anniversary of the Termination Date or (B) the final expiration date for such Options as provided for in the applicable
Award Agreement. In the event of any conflict between the terms of this Section 8(b) and the terms of any Award Agreement
heretofore or hereafter granted to the Executive, the terms of this Section 8(b) shall control and govern.

9.         Termination Upon Expiration. If the Executive shall cease being an employee of the
Company on account of a Termination Upon Expiration, the Executive shall have no further rights against the Company hereunder after
the Termination Date, except for the right to receive (i) any Base Salary and bonus compensation earned but unpaid as of the
Termination Date, (ii) accrued vacation and other vested benefits; and (iii) reimbursement of business expenses to which the
Executive is entitled as of the Termination Date under Section 5(a). In the event of any Termination Upon Expiration, the
Executive shall continue to be subject to the Confidentiality Agreement. In the event of a Termination Upon Expiration caused by
the Company (i.e., the Company gave notice to the Executive of the Company’s election to not extend the Term pursuant to
Section 3(a)), then (a) solely for purposes of any Award Agreement granted to the Executive, the Termination Upon Expiration
shall not constitute a voluntary termination of the Executive’s employment by the Executive, and (b) the Executive shall
not be subject to the Non-Compete Agreement following the Termination Date. In the event of a Termination Upon Expiration caused
by the Executive (i.e., the Executive gave notice to the Company of the Executive’s election to not extend the Term pursuant
to Section 3(a)), then (x) solely for purposes of any Award Agreement granted to the Executive, the Termination Upon Expiration
shall constitute a voluntary termination of employment by the Executive, and (y) the Executive shall continue to be subject to
the Non-Compete Agreement following the Termination Date.

10.       Change of Control.

(a)        Accelerated Vesting. Notwithstanding the terms of any Award Agreement heretofore or
hereafter granted to the Executive, in the event of a Change of Control, all Options and Restricted Stock granted to the Executive
which do not constitute deferred compensation for Code Section 409A purposes shall become fully vested on the date of the Change
of Control and immediately prior to the time of the Change of Control. In the event of any conflict between the terms of this Section
10(a) and the terms of any Award Agreement heretofore or hereafter granted to the Executive, the terms of this Section 10(a)
shall control and govern.

(b)        Change of Control Termination. Notwithstanding any other provision in this Agreement
to the contrary, in the event of a Change of Control Termination, the Company shall, on the

 

    		9	 

     

    

Termination Date, pay the Executive
a lump sum amount which is equal to the sum of: (i) the product of (A) the Executive’s Base Salary in effect as of the Termination
Date multiplied by (B) two (2), plus (ii) the product of (A) the average of the two highest annual cash bonuses paid to the
Executive for the three years preceding the year in which the Termination Date occurs, if any, multiplied by (B) two (2); plus
(iii) Eighteen Thousand Dollars ($18,000); plus (iv) any Base Salary and bonus compensation earned but unpaid as of the Termination
Date, plus (v) any unreimbursed business expenses to which the Executive is entitled as of the Termination Date under Section 5(a).
The Company shall also pay the Executive any amounts due to the Executive pursuant to the terms of any Award Plans and/or Benefit
Plans in which the Executive was a participant, in accordance with the terms of such plans. Notwithstanding the foregoing, if the
Executive is a Specified Employee and the total of the payments under this Section 10(b) exceeds the limit set forth in
Treas. Reg. §1.409A-1(b)(9)(iii)(A) (related to separation pay), then the amount in excess of such limit shall be delayed
for six (6) months following the Executive’s Termination Date, and such delayed amount shall be paid in a lump sum after
the end of the six-month delay. In the event of a Change of Control Termination, the Executive shall continue to be subject to
the Confidentiality Agreement and the Non-Compete Agreement.

(c)        Options. Notwithstanding the terms of any Award Agreement heretofore or hereafter granted
to the Executive, in the event of a Change of Control Termination, the Executive shall continue to have the right to exercise any
Options granted to the Executive prior to the Change of Control until the earlier to occur of (A) the three (3) year anniversary
of the Termination Date or (B) the final expiration date for such Options as provided for in the applicable Award Agreement. In
the event of any conflict between the terms of this Section 10(c) and the terms of any Award Agreement heretofore or hereafter
granted to the Executive, the terms of this Section 10(c) shall control and govern.

11.       Maximum Net After-Tax Benefit.

(a)        Potential Reduction in Total Payments. It is the parties’ objective to maximize
the Executive’s Net After-Tax Benefit if any payments or benefits provided hereunder would be subject to the Excise Tax.
Accordingly, in the event the Company or the Executive believes that the Total Payments to or for the benefit of the Executive,
whether paid or payable or distributed or distributable or otherwise, including, by example and not by way of limitation, acceleration
of the date of vesting or payment under any agreement, arrangement, plan or program, would be subject to the Excise Tax, calculations
shall be made to determine (i) the maximum amount of payments and benefits that may be provided to the Executive so that no portion
thereof will be subject to the Excise Tax (the “Section 4999 Limit”), (ii) the Executive’s Net After-Tax
Benefit assuming application of the Section 4999 Limit, and (iii) the Executive’s Net After-Tax Benefit without the application
of the Section 4999 Limit. Based on such calculations or otherwise, and notwithstanding anything contained in this Agreement to
the contrary, the Executive may elect to reduce the amount of the Total Payments up to the Section 4999 Limit so that no portion
of the Total Payments received by the Executive will be subject to the Excise Tax. Alternatively, the Executive may elect to receive
all Total Payments, in which case the Executive shall be solely liable for any and all Excise Tax related thereto.

(b)         Manner of Determination. Unless otherwise agreed between the Company and the Executive,
all calculations required to be made under this Section 11 shall be made, at the Company’s expense, by the accounting
firm which is the Company’s accounting firm immediately prior to the Change of Control or another nationally recognized accounting
firm designated by the Board (or a duly authorized committee thereof) prior to the Change of Control (the “Accounting
Firm”). The Accounting Firm shall provide its calculations, together with supporting documentation, both to the Company
and to the Executive at such time as reasonably requested by the Company or the Executive.

 

    		10	 

     

    

(c)         Order of Reduction. If the Executive elects to reduce the Total Payments as contemplated
in Section 11(a), the Executive may select the order of reduction; provided, however, that none of the selected payments
may be “nonqualified deferred compensation” subject to Section 409A of the Code. In the event the Executive fails to
select an order in which Total Payments are to be reduced, or does not select such an order without selecting payments that would
be “nonqualified deferred compensation” subject to Section 409A of the Code, the Company shall (to the extent feasible)
reduce the Total Payments in the following order: (i) reduction of any cash severance payments otherwise payable to the Executive
that are exempt from Section 409A of the Code; (ii) reduction of any other cash payments or benefits otherwise payable to the Executive
that are exempt from Section 409A of the Code, but excluding any payments attributable to any acceleration of vesting or payments
with respect to any Options or other equity or equity-type awards that are exempt from Section 409A of the Code; (iii) reduction
of any other payments or benefits otherwise payable to the Executive on a pro rata basis or in such other manner that complies
with Section 409A of the Code, but excluding any payments attributable to any acceleration of vesting and payments with respect
to any Options or other equity or equity-type awards that are exempt from Section 409A of the Code; and (iv) reduction of any payments
attributable to any acceleration of vesting or payments with respect to any Options or other equity or equity-type awards that
are exempt from Section 409A of the Code; in each case beginning with payments that would otherwise be made last in time.

12.        Exclusive Remedy. To the extent permitted by applicable law, the payments contemplated
by Section 7, Section 8, Section 9 and Section 10 shall constitute the exclusive and sole remedy for any termination
of the Executive’s employment due to death or Permanent Disability, any Termination Without Cause, any Termination for Good
Reason or any Termination Upon Expiration. The Executive agrees, for himself and any administrator, beneficiary, devisee, executor,
heir, legatee or personal representative, (i) to not assert or pursue any remedies, other than an action to enforce the payments
due to the Executive (or the Executive’s estate) under this Agreement, at law or in equity, with respect to the termination
of the Executive’s employment under Section 7, Section 8, Section 9 or Section 10, as applicable,
and (ii) to execute a release and waiver on such terms and conditions as the Company may reasonably require as a condition of entitlement
to such payments.

13.        Confidentiality and Noncompetition. The Executive shall enter into the Confidentiality
Agreement and Non-Compete Agreement. The Executive’s execution of those agreements is a material inducement for the Company
to enter into this Agreement. Therefore, this Agreement will be null and void unless the Executive enters into the Confidentiality
Agreement and the Non-Compete Agreement.

14.        Employment Status. The parties acknowledge and agree that the Executive is an employee
of the Company, not an independent contractor. Any payments made to the Executive by the Company pursuant to this Agreement shall
be treated for federal and state payroll tax purposes as payments made to a Company employee, irrespective whether such payments
are made subsequent to the Termination Date.

15.        Notices. All notices or deliveries authorized or required pursuant to this Agreement
shall be deemed to have been given when in writing and personally delivered or when deposited in the U.S. mail, certified, return
receipt requested, postage prepaid, addressed to the parties at the following addresses or to such other addresses as either may
designate in writing to the other party:

 

	To the Company:	
        MRI Interventions, Inc.

        5 Musick

        Irvine, CA 92618

         

	To the Executive:	
        Joseph Michael Burnett

        1968 Manchester Ave.

        Cardiff, CA 92007

 

    		11	 

     

    

16.        Entire Agreement. This Agreement contains the entire understanding between the parties
hereto with respect to the subject matter hereof and shall not be modified in any manner except by instrument in writing signed,
by or on behalf of, the parties hereto. This Agreement shall be binding upon and inure to the benefit of the heirs, successors
and assigns of the parties hereto. In the event of any inconsistencies between the terms of this Agreement and any Award Agreement,
the terms of this Agreement shall govern.

17.        Certain 409A Matters. Notwithstanding any provision herein to the contrary, for purposes
of identifying Specified Employees or determining when a Termination of Employment has occurred or for any other purpose where
Section 409A of the Code applies, references to the Company shall be deemed to include Affiliates of the Company which are required
to be aggregated with the Company under Section 409A of the Code.

18.        Applicable Law. This Agreement shall be governed and construed in accordance with the
laws of the State of Delaware without giving effect to conflict of laws principles thereof.

19.        Assignment. The Executive acknowledges that his services are unique and personal. Accordingly,
the Executive may not assign his rights or delegate his duties or obligations under this Agreement.

20.        Headings. Headings in this Agreement are for convenience only and shall not be used
to interpret or construe its provisions.

21.        Successors; Binding Agreement. The Company will require any successor to all or substantially
all of the business and/or assets of the Company to expressly assume and agree to perform this Agreement in the same manner and
to the same extent that the Company would be required to perform it if no such succession had taken place. Failure of the Company
to obtain such assumption and agreement prior to the effectiveness of any such succession shall be a breach of this Agreement and
shall entitle Executive to compensation from the Company in the same amount and on the same terms as Executive would be entitled
to hereunder upon a Change of Control Termination. The Company’s rights and obligations under this Agreement shall inure
to the benefit of and shall be binding upon the Company’s successors and assigns. 

 

 

 

[The remainder of this page is intentionally
left blank.]

 

 

 

    		12	 

     

    

IN WITNESS WHEREOF,
the parties have executed this Agreement effective as of the date first above written.

 

	MRI INTERVENTIONS, INC.
	 	 
	 	 
	By:	/s/ Harold A. Hurwitz
	Name:	Harold A. Hurwitz
	Title:	Chief Financial Officer
	 	 
	 	 
	 	 
	EXECUTIVE:
	 	 
	 	 

	 	/s/ Joseph Michael Burnett
	 	Joseph Michael Burnett
	 	 

 

 

 

    		13	 

     

    

 

Exhibit A

 

NON-DISCLOSURE AND PROPRIETARY RIGHTS AGREEMENT

 

 

See Attached

 

 

 

    	 

    	 

    

mri interventions,
INC.

 

Non-Disclosure
AND PROPRIETARY RIGHTS Agreement

 

In consideration and as
a condition of my employment (or my continued employment) with MRI Interventions, Inc., or any of its current or future subsidiaries,
affiliates, successors or assigns (collectively, the “Company”), and in consideration of my receipt of Confidential
Information (as defined in Section 2 below) and of the compensation now and hereafter paid to me by the Company, the undersigned
(hereinafter referred to as “Employee”) hereby acknowledges and agrees to the following:

1.               
Purpose of Agreement. Employee understands that the Company is engaged in a continuous
program of research, development, production and marketing in connection with its business and that it is critical for the Company
to preserve and protect its Confidential Information (as defined in Section 2 below), its rights in Inventions (as defined
in Section 7 below) and in all related intellectual property rights. Accordingly, Employee is entering into this Non-Disclosure
and Proprietary Rights Agreement (this “Agreement”) as a condition of his or her employment (or continued employment)
with the Company, regardless of whether Employee is expected to create Inventions of value for the Company.

 

2.               
Non-Disclosure of Confidential Information. At all times during his or her employment
with the Company and thereafter, Employee will hold the Confidential Information in strictest confidence and Employee will not
disclose, communicate, reproduce, copy, publish, license, distribute, modify, adapt, transmit, reverse engineer, decompile, disassemble
or use any Confidential Information, except (a) as may be necessary for Employee to perform his or her duties as an employee of
the Company for the exclusive benefit of the Company or (b) to the extent an officer of the Company expressly authorizes such in
writing. Employee will take all appropriate action, whether by instruction, agreement or otherwise, to ensure the protection, confidentiality
and security of the Confidential Information and to satisfy Employee’s obligations under this Agreement. Employee will notify
the Company immediately upon discovery of any loss, misuse, misappropriation or disclosure of Confidential Information or any other
breach of this Agreement by Employee, and Employee will cooperate with the Company in every reasonable way to help the Company
regain possession of the Confidential Information and prevent its further unauthorized use or disclosure.

 

For purposes of this Agreement,
the term “Confidential Information” means, but is not limited to, all information that is possessed by or developed
for the Company and which relates to the Company’s existing or potential business, which information is not reasonably knowable
by the Company’s competitors or by the general public through lawful means. Without limiting the generality of the foregoing,
such Confidential Information also includes, but is not limited to, all Proprietary Rights (as defined in Section 3 below),
all Third Party Information (as defined in Section 4 below) and all information regarding the Company’s operations,
research and development efforts, plans for products or services, methods of doing business, business strategies, customers, suppliers,
service providers, manufacturers, business relations, product prices and costs, markets, marketing plans, budgets and forecasts,
financial information and/or Inventions, as well as information regarding the skills, know how and compensation of other employees
of the Company. Confidential Information may be expressly designated as confidential or proprietary on its face (whether verbally,
in writing or otherwise) or be of such a nature that a reasonable person under the circumstances should understand or believe it
to be confidential or proprietary. Confidential Information may be oral, written, recorded magnetically or electronically or otherwise
stored, and may be that which Employee originates as well as that which otherwise comes into the possession or knowledge of Employee.

 

3.               
Recognition of Company’s Rights. Employee acknowledges and agrees that all Confidential
Information will be the sole property of the Company and that the Company will be the sole

 

    		1	 

     

    

owner of all patents, patent applications,
design patents or registration, design patent applications, copyrights, mask works, trademarks, trade secrets and all other intellectual
property rights throughout the world (collectively, “Proprietary Rights”) in connection therewith. Accordingly,
Employee hereby assigns and agrees to assign to the Company any rights Employee may have or acquire in any Confidential Information
and Proprietary Rights.

 

4.               
Non-Disclosure of Third Party Information. Employee understands that the Company may
from time to time receive from third parties confidential information (“Third Party Information”), subject to
a duty on the Company's part to maintain the confidentiality of such information and to use it only for certain limited purposes.
At all times during Employee’s employment with the Company and thereafter, Employee will hold the Third Party Information
in strictest confidence and Employee will not disclose, communicate, reproduce, copy, publish, license, distribute, modify, adapt,
transmit, reverse engineer, decompile, disassemble or use any Third Party Information, except (a) as may be necessary for Employee
to perform his or her duties as an employee of the Company for the exclusive benefit of the Company or (b) to the extent an officer
of the Company expressly authorizes such in writing. Employee will take all appropriate action, whether by instruction, agreement
or otherwise, to ensure the protection, confidentiality and security of the Third Party Information and to satisfy Employee’s
obligations under this Agreement. Employee will notify the Company immediately upon discovery of any loss, misuse, misappropriation
or disclosure of Third Party Information or any other breach of this Agreement by Employee, and Employee will cooperate with the
Company in every reasonable way to help the Company prevent its further unauthorized use or disclosure.

 

5.               
Return of Information; Inspections. Employee will, at the Company’s request and/or
upon termination of the employment relationship for any reason, return all originals, copies, reproductions and summaries of any
Confidential Information and all other tangible materials and devices provided to Employee as Confidential Information or containing
Confidential Information, and/or, at the Company’s option, certify destruction of the same. In addition, Employee will, at
the Company’s request and/or upon termination of the employment relationship for any reason, return all originals, copies,
reproductions and summaries of any Third Party Information and all other tangible materials and devices provided to Employee as
Third Party Information or containing Third Party Information, and/or, at the Company’s option, certify destruction of the
same. Upon termination of his or her employment with the Company, Employee will promptly deliver to the Company all property in
Employee’s possession, custody or control that is owned by the Company. Employee agrees that any property situated on the
Company’s premises and owned by the Company, including, but not limited to, computers, disks and other storage media, is
subject to inspection by Company personnel at any time without notice.

 

6.               
No Improper Use of Materials. During his or her employment with the Company, Employee
will not improperly use or disclose any Confidential Information or trade secrets, if any, of any former employer or any other
person to whom Employee has an obligation of confidentiality, and Employee will not bring onto the premises of the Company any
unpublished documents or any property belonging to any former employer or any other person to whom Employee has an obligation of
confidentiality unless consented to in writing by that former employer or person.

 

7.               
Assignment of Inventions. Employee hereby irrevocably assigns to the Company all right,
title and interest of Employee in and to any and all Inventions (and all Proprietary Rights with respect thereto), whether or not
patentable, copyrightable or protectable as trade secrets, made, conceived, reduced to practice or created by Employee, either
alone or jointly with others, during the period of his or her employment with the Company. Employee acknowledges that all original
works of authorship which are made by Employee (alone or jointly with others) within the scope of his or her employment and which
are copyrightable are "works made for hire," as that term is defined in the United States Copyright Act. In addition
to the foregoing assignment of Inventions (and all Proprietary Rights with respect thereto) to 

 

    		2	 

     

    

the Company, Employee hereby irrevocably
assigns to the Company any and all Moral Rights (as defined below) that Employee may have in or with respect to any Invention,
and Employee forever waives and agrees not to assert any and all Moral Rights he or she may have in or with respect to any Invention,
even after termination of employment with the Company. 

 

For purposes of this Agreement,
the term “Inventions” means inventions, discoveries, improvements, designs, techniques, ideas, processes, compositions
of matter, formulas, data, software programs, databases, mask works, works of authorship, know-how and trade secrets.

 

For purposes of this Agreement,
the term “Moral Rights” means any right to claim authorship of an Invention, to object to or prevent the modification
of any Invention, or to withdraw from circulation or control the publication or distribution of any Invention, and any similar
right, existing under judicial or statutory law of any country or under any treaty, regardless of whether such right is denominated
or generally referred to as a “moral right.”

 

8.               
Disclosure of Inventions. Employee will promptly disclose to the Company all Inventions
that Employee makes, conceives, reduces to practice or creates, either alone or jointly with others, during the period of his or
her employment with the Company. In addition, Employee will disclose to the Company all patent applications filed by Employee within
three (3) years after termination of employment with the Company.

 

9.               
Assistance. Employee agrees to assist the Company in every proper way to obtain and,
from time to time, enforce United States and foreign Proprietary Rights relating to Inventions assigned hereunder to the Company
in any and all countries. To that end, Employee will execute, verify and deliver such documents and perform such other acts (including
appearances as a witness) as the Company may reasonably request for use in applying for, obtaining, perfecting, evidencing, sustaining
and enforcing such Proprietary Rights and the assignment thereof. In addition, Employee will execute, verify and deliver assignments
of such Proprietary Rights to the Company or its designee. Employee’s obligation to assist the Company with respect to Proprietary
Rights relating to Inventions in any and all countries will continue beyond the termination of Employee’s employment, but
the Company agrees to compensate Employee at a reasonable rate after Employee’s termination for the time actually spent by
Employee at the Company's request on such assistance. Employee hereby irrevocably designates and appoints the Company and its duly
authorized officers and agents as Employee’s agent and attorney-in-fact to act for and on behalf of Employee (a) to execute,
verify and file any document needed in connection with the actions specified in this section and (b) to do all other lawfully permitted
acts to further the purposes of this section, in each case with the same legal force and effect as if executed or performed by
Employee. Employee hereby waives and quitclaims to the Company any and all claims, of any nature whatsoever, which Employee now
or may hereafter have for infringement of any Proprietary Rights assigned hereunder to the Company.

 

10.            
Prior Inventions. Inventions, if any, which Employee made prior to the commencement
of his or her employment with the Company are excluded from the scope of this Agreement. To preclude any possible uncertainty,
Employee has set forth on Exhibit A hereto a complete list of all Inventions that Employee, whether alone or jointly with
others, has conceived, developed or reduced to practice or caused to be conceived, developed or reduced to practice prior to commencement
of his or her employment with the Company, that Employee considers to be his or her property or the property of third parties and
that Employee wishes to have expressly excluded from the scope of this Agreement.

 

11.            
Efforts; Non-Competition. Employee acknowledges that his or her employment with the
Company requires his or her full attention and effort during normal business hours, and Employee will give his or her best effort,
skill and inventive ability to the business interests of the Company. During the 

 

    		3	 

     

    

term of his or her employment with the Company,
Employee will not, directly or indirectly, participate in the management, operation, financing or control of, or be employed by
or consult for or otherwise render services to, any person or entity that competes anywhere in the world with the Company in the
conduct of the business of the Company as conducted or as proposed to be conducted (a “Competing Business”),
nor will Employee engage in any other activities that conflict with his or her obligations to the Company.

 

12.            
Non-Solicitation. During the term of his or her employment by the Company and for a
period of two (2) years after the date his or her employment with the Company ends for any reason, Employee will not, directly
or indirectly, (a) hire, engage or solicit to hire or engage any individual who is engaged as a contractor or consultant or employed
by the Company or who was engaged as a contractor or consultant or employed by the Company within six months of the proposed solicitation,
hire or engagement, (b) otherwise induce or attempt to induce any individual who is engaged as a contractor or consultant or employed
by the Company to terminate such engagement or employment, (c) in any way interfere with the relationship between the Company and
any individual who is engaged as a contractor or consultant or employed by the Company; (d) contact, solicit, divert, appropriate
or call upon with the intent of doing business with (other than for the exclusive benefit of the Company) any customer of the Company
if the purpose of such activity is to solicit such customer or prospective customer for a Competing Business, to encourage such
customer to discontinue, reduce or adversely alter the amount of such customer’s business with the Company or to otherwise
interfere with the Company’s relationship with such customer, or (e) in any way interfere with the Company’s relationship
with any supplier, manufacturer, service provider or other business relation of the Company.

 

13.            
No Conflicting Obligation. Employee represents and agrees that his or her performance
of the provisions of this Agreement does not, and will not, breach any agreement to keep in confidence information acquired by
Employee in confidence or in trust prior to his or her employment by the Company. Employee agrees not to enter into any agreement,
either written or oral, in conflict herewith.

 

14.            
Reasonableness of Restrictions. Employee agrees that the restrictions on Employee’s
activities outlined in this Agreement are reasonable and necessary to protect the Company’s legitimate business interests,
that the consideration provided by the Company is fair and reasonable, and that given the importance to the Company of its Confidential
Information, the post-employment restrictions on Employee’s activities are likewise fair and reasonable. 

 

15.            
Injunctive Relief. Employee acknowledges and agrees that failure to adhere to the terms
of this Agreement will cause the Company irreparable damage for which monetary damages alone would be inadequate compensation.
Therefore, Employee agrees that, in addition to monetary damages, the Company will be entitled to an injunction and other equitable
relief, including ex parte injunctive relief, in the event of any breach or threatened breach (such threatened breach being
determined in the sole judgment of the Company) of the provisions of this Agreement. Employee waives the making of a bond or showing
actual damages as a condition for obtaining injunctive relief. Such remedy shall not be deemed the exclusive remedy for the breach
of this Agreement by Employee, but will be in addition to all other remedies available to the Company whether at law or in equity.
Additionally, if Employee breaches this Agreement, the Company will be entitled to its reasonable attorney’s fees and costs
associated with enforcing this Agreement. Notwithstanding any judicial determination that any provision of this Agreement is not
specifically enforceable, the Company will nonetheless be entitled to recover monetary damages as a result of any breach by Employee.

 

16.            
Governing Law. This Agreement will be governed by and construed in accordance with
the internal laws of the state of Delaware, without giving any effect to that state’s conflict of laws principles. 

 

    		4	 

     

    

17.            
Employment. Employee acknowledges and agrees that this Agreement does not create an
employment contract with the Company for any term, nor does it in any way limit the Company’s right to otherwise terminate
Employee’s employment. Any change or changes in Employee’s duties, salary or compensation will not affect the validity
or scope of this Agreement.

 

18.            
Severability. Whenever possible, each provision of this Agreement will be interpreted
in a manner to be effective, valid and enforceable. If, however, any provision of this Agreement is held to be illegal, invalid
or unenforceable under any present or future law, then such provision will be ineffective only to the extent of such prohibition
or invalidity, without invalidating or affecting in any manner whatsoever the remainder of such provision or the remaining provisions
of this Agreement. Furthermore, there shall be added automatically as a part of this Agreement a provision as similar in terms
to such illegal, invalid, or unenforceable provision as may be possible and still have such similar provision be construed and
enforced as legal, valid, and enforceable.

 

19.            
Amendments; Waivers. No modification or amendment to this Agreement, nor any waiver
of any rights under this Agreement, will be effective unless in writing signed by the party to be charged. No waiver by the Company
of any breach of this Agreement will be a waiver of any preceding or succeeding breach.

 

20.            
Assignment. The Company may assign its rights under this Agreement. This Agreement,
and the duties and obligations of Employee hereunder, may not be assigned or delegated by Employee.

 

21.            
Survival. The terms of this Agreement, and Employee’s duties and obligations
hereunder, will survive any termination of Employee’s employment with the Company for any reason.

 

22.            
Headings. Headings in this Agreement are for informational purposes only and will not
be used to construe the intent of this Agreement.

 

23.            
Entire Agreement. This Agreement constitutes the entire agreement and understanding
between the Company and Employee concerning the matters addressed herein. 

 

24.            
Further Assurances. Employee will cooperate reasonably with the Company in connection
with any steps required to be taken as part of Employee’s obligations under this Agreement, and Employee will (a) execute
and deliver to the Company such other documents, and (b) do such other acts and things, in each case as the Company may reasonably
request for the purpose of carrying out the provisions of this Agreement.

 

    		5	 

     

    

 

25.            
Acknowledgment. Employee acknowledges that he or she has received a copy of this Agreement,
which he or she has read and understood, and Employee voluntarily agrees to abide by its terms. Employee authorizes the Company
to notify any future employer(s) of Employee of the terms of this Agreement and Employee’s obligations hereunder.

 

*****

 

 

	/s/ Joseph Michael Burnett	 	10/6/2017
	Employee Signature	 	Date
	 	 	 
	 	 	 
	Joseph Michael Burnett	 	 
	Employee Name	 	 
	 	 	 
	Accepted by:	 	 
	 	 	 
	MRI Interventions, Inc.	 	 

 

 

	By:	/s/ Harold A. Hurwitz
	Name:	Harold A. Hurwitz
	Title:	Chief Financial Officer

 

 

 

    		6	 

     

    

Exhibit A

 

 

The following is a complete list of all inventions
or improvements relevant to the subject matter of my employment with the Company that have been made, conceived, first reduced
to practice or created by me, alone or jointly with others, prior to my employment with the Company that I desire to remove from
the operation of the Company's Non-Disclosure and Proprietary Rights Agreement:

 

☒       No
inventions or improvements

 

☐       See
below:

 

		 	 

 

		 	 

 

		 	 

 

 

☐       Additional
sheets attached.

 

 

I propose to bring to my employment the following
materials and documents of a former employer:

 

☒       No
materials or documents

 

☐       See
below:

 

		 	 

 

		 	 

 

		 	 

 

 

☐       Additional
sheets attached.

 

 

	/s/ Joseph Michael Burnett	 	10/6/2017
	Employee Signature	 	Date
	 	 	 
	 	 	 
	Joseph Michael Burnett	 	 
	Employee Name	 	 

 

 

    	 

    	 

    

Exhibit B

 

NON-COMPETITION AGREEMENT

 

See Attached

 

 

 

 

 

 

    	 

    	 

    

MRI INTERVENTIONS,
INC.

 

Non-COMPETITION
Agreement

 

In consideration
and as a condition of my employment (or my continued employment) with MRI Interventions, Inc., or any of its current or future
subsidiaries, affiliates, successors or assigns (collectively, the “Company”), and in consideration of my receipt
of the compensation now and hereafter paid to me by the Company, the undersigned (hereinafter referred to as “Employee”)
hereby acknowledges and agrees to the following:

1.               
Defined Terms. For purposes of this Agreement, the following terms have the meanings
specified or referred to in this Section 1:

 

(a)       “Conflicting
Organization” means any individual or entity that, directly or indirectly, engages in, or is about to become engaged
in, Conflicting Research or the development, design, production, manufacture, promotion, marketing, sale, support or service of
a Conflicting Product.

 

(b)       “Conflicting
Product” means medical devices, goods, products, product lines or services, and each and every component thereof, developed,
designed, produced, manufactured, marketed, promoted, sold, supported or serviced, or that are in development or the subject of
research, by anyone other than the Company that are the same or similar to, perform any of the same or similar functions as, may
be substituted for, or are intended or used for any of the same purposes as, a Company Product.

 

(c)       “Conflicting
Research” means any research or development of any kind or nature conducted by anyone other than the Company, which is
intended for, or may be useful in, any aspect of the development, design, production, manufacture, marketing, promotion, sale,
support or service of a Conflicting Product.

 

(d)       “Company
Product” means any medical device, goods, products, product lines or services (i) that during the last one (1) year in
which Employee was employed by the Company, Employee, or persons under Employee’s management, direction or supervision, performed
research regarding, designed, developed, produced, manufactured, marketed, promoted, sold, solicited sales of, supported or serviced
on behalf of the Company, or (ii) with respect to which Employee at any time received or otherwise obtained or learned Confidential
Information.

 

(e)       “Restricted
Area” means the United States of America or in any other country in which the Company has received or applied for regulatory
clearances or approvals for Company Products.

 

2.               
Efforts; Non-Competition. Employee acknowledges that his or her employment with the
Company requires his or her full attention and effort during normal business hours, and Employee will give his or her best effort,
skill and inventive ability to the business interests of the Company. During the term of his or her employment with the Company,
Employee will not, directly or indirectly, participate in the management, operation, financing or control of, or be employed by
or consult for or otherwise render services to, any individual or entity that competes with the Company in the Restricted Area
in the conduct of the business of the Company as conducted or as proposed to be conducted, nor will Employee engage in any other
activities that conflict with his or her obligations to the Company.

 

In addition, for a period
of one (1) year after the date his or her employment with the Company ends for any reason, Employee will not, directly or indirectly,
participate in the management, operation, financing or control of, or be employed by or consult for or otherwise render services
to, any Conflicting Organization in the Restricted Area in connection with or relating to a Conflicting Product or Conflicting
Research.

 

    	 	 	 

     

    

3.               
No Conflicting Obligation. Employee represents and agrees that his or her performance
of the provisions of this Agreement does not, and will not, breach any agreement to keep in confidence information acquired by
Employee in confidence or in trust prior to his or her employment by the Company. Employee agrees not to enter into any agreement,
either written or oral, in conflict herewith.

 

4.               
Reasonableness of Restrictions. Employee agrees that the restrictions on Employee’s
activities outlined in this Agreement are reasonable and necessary to protect the Company’s legitimate business interests,
that the consideration provided by the Company is fair and reasonable, and that the post-employment restrictions on Employee’s
activities are fair and reasonable. 

 

5.               
Injunctive Relief. Employee acknowledges and agrees that failure to adhere to the terms
of this Agreement will cause the Company irreparable damage for which monetary damages alone would be inadequate compensation.
Therefore, Employee agrees that in addition to monetary damages, the Company will be entitled to an injunction and other equitable
relief, including ex parte injunctive relief, in the event of any breach or threatened breach (such threatened breach being
determined in the sole judgment of the Company) of the provisions of this Agreement. Employee waives the making of a bond or showing
actual damages as a condition for obtaining injunctive relief. Such remedy shall not be deemed the exclusive remedy for the breach
of this Agreement by Employee, but will be in addition to all other remedies available at law or in equity to the Company. Additionally,
if Employee breaches this Agreement, the Company will be entitled to its reasonable attorney’s fees and costs associated
with enforcing this Agreement. Notwithstanding any judicial determination that any provision of this Agreement is not specifically
enforceable, the Company will nonetheless be entitled to recover monetary damages as a result of any breach by Employee.

 

6.               
Governing Law. This Agreement will be governed by and construed in accordance with
the internal laws of the state of Delaware, without giving any effect to that state’s conflict of laws principles.

 

7.               
Employment. Employee acknowledges and agrees that this Agreement does not create an
employment contract with the Company for any term, nor does it in any way limit the Company’s right to otherwise terminate
Employee’s employment. Any change or changes in Employee’s duties, salary or compensation will not affect the validity
or scope of this Agreement.

 

8.               
Severability. Whenever possible, each provision of this Agreement will be interpreted
in a manner to be effective, valid and enforceable. If, however, any provision of this Agreement is held to be illegal, invalid
or unenforceable under any present or future law, then such provision will be ineffective only to the extent of such prohibition
or invalidity, without invalidating or affecting in any manner whatsoever the remainder of such provision or the remaining provisions
of this Agreement. Furthermore, there shall be added automatically as a part of this Agreement a provision as similar in terms
to such illegal, invalid, or unenforceable provision as may be possible and still have such similar provision be construed and
enforced as legal, valid, and enforceable.

 

9.               
Amendments; Waivers. No modification or amendment to this Agreement, nor any waiver
of any rights under this Agreement, will be effective unless in writing signed by the party to be charged. No waiver by the Company
of any breach of this Agreement will be a waiver of any preceding or succeeding breach.

 

    	 	 	 

     

    

10.            
Assignment. The Company may assign its rights under this Agreement. This Agreement,
and the duties and obligations of Employee hereunder, may not be assigned or delegated by Employee.

 

11.            
Survival. The terms of this Agreement, and Employee’s duties and obligations
hereunder, will survive any termination of Employee’s employment with the Company for any reason.

 

12.            
Headings. Headings in this Agreement are for informational purposes only and will not
be used to construe the intent of this Agreement.

 

13.            
Entire Agreement. This Agreement constitutes the entire agreement and understanding
between the Company and Employee concerning the matters addressed herein. 

 

14.            
Further Assurances. Employee will cooperate reasonably with the Company in connection
with any steps required to be taken as part of Employee’s obligations under this Agreement, and Employee will (a) execute
and deliver to the Company such other documents, and (b) do such other acts and things, in each case as the Company may reasonably
request for the purpose of carrying out the provisions of this Agreement.

15.            
Acknowledgment. Employee acknowledges that he or she has received a copy of this Agreement,
which he or she has read and understood, and Employee voluntarily agrees to abide by its terms. Employee authorizes the Company
to notify any future employer(s) of Employee of the terms of this Agreement and Employee’s obligations hereunder.

 

	/s/ Joseph Michael Burnett	 	10/6/2017
	Employee Signature	 	Date
	 	 	 
	 	 	 
	Joseph Michael Burnett	 	 
	Employee Name	 	 
	 	 	 
	 	 	 
	Accepted by:	 	 
	 	 	 
	MRI Interventions, Inc.	 	 

 

	By:	/s/ Harold A. Hurwitz
	Name:	Harold A. Hurwitz
	Title:	Chief Financial Officer

 

 

    	 

    	 

    

Exhibit C

 

NON-QUALIFIED STOCK OPTION AGREEMENT

 

See Attached

 

 

 

 

 

 

    	 

    	 

    

THIS OPTION AND THE SECURITIES ISSUABLE
UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),
OR APPLICABLE STATE SECURITIES LAWS. THIS OPTION, AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF, MAY NOT BE SOLD, MORTGAGED,
PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND ANY APPLICABLE
STATE SECURITIES LAWS, OR THE AVAILABILITY OF AN EXEMPTION FROM THE REGISTRATION PROVISIONS OF THE SECURITIES ACT AND APPLICABLE
STATE SECURITIES LAWS.

 

MRI INTERVENTIONS, INC.

NON-QUALIFIED STOCK OPTION AGREEMENT

 

THIS NON-QUALIFIED STOCK
OPTION AGREEMENT (this “Agreement”) is made effective as of the 7th day of November 2017 (the “Effective
Date”), by and between MRI INTERVENTIONS, INC., a Delaware corporation (the “Company”), and
JOSEPH MICHAEL BURNETT (the “Optionee”).

 

WHEREAS, the Company
desires to afford the Optionee an opportunity to purchase shares of the Company’s common stock, par value $.01 per share
(the “Shares”), subject to the terms and conditions hereinafter set forth.

 

NOW, THEREFORE,
in consideration of the mutual covenants hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the parties hereto, intending to be legally bound hereby, agree as follows:

1.               
Grant of Option.

(a)             
The Company grants, as of the Effective Date, the right and option (the “Stock Option”)
to purchase three hundred fifty thousand (350,000) Shares, in whole or in part (the “Option Shares”), at an
exercise price of $_____ per Share (the “Option Exercise Price Per Share”), on the terms and conditions set
forth in this Agreement.

(b)            
The Stock Option shall be a non-qualified stock option. The Stock Option is not intended to
be an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”).
In order to comply with all applicable federal or state tax laws or regulations, the Company may take such action as it deems appropriate
to insure that, if necessary, all applicable federal, state or other taxes are withheld or collected from the Optionee. This Agreement
is not subject to, and the Stock Option is not granted under, the Company’s 2013 Incentive Compensation Plan, as amended
and restated (the “2013 Plan”). 

2.               
Exercisability Schedule. No portion of the Stock Option may be exercised until such
portion shall have become exercisable. Except as set forth below, and subject to the discretion of the Company’s Board of
Directors or a duly authorized committee thereof (in either case, the “Board”) to accelerate the exercisability
schedule hereunder, the Stock Option shall be exercisable with respect to the following number of Option Shares on the dates indicated:

    	 	 	 

     

    

	
        Incremental Number of

        Option Shares Exercisable
	 	
         

        Exercisability Date

	116,666	 	On the first anniversary of the Effective Date
	29,166	 	Every three (3) months thereafter up to but not including the Final Vesting Date
	29,172	 	On the third anniversary of the Effective Date (the “Final Vesting Date”)
	 	 	 

Notwithstanding anything
herein to the contrary, in the event of a Change of Control, the Stock Option shall become fully exercisable as of the effective
time of the Change of Control. For purposes of this Agreement, the term “Change of Control” shall have the same meaning
given to that term in the 2013 Plan.

3.               
Manner of Exercise. 

(a)       The
Optionee may exercise the Stock Option only in the following manner:

The Optionee may give
written notice to the Company of his election to purchase some or all of the Option Shares purchasable at the time of such notice.
This notice shall specify the number of Option Shares to be purchased.

Payment of the purchase
price for the Option Shares may be made by one or more of the following methods: (i) in cash or its equivalent (e.g., by personal
check) at the time the Stock Option is exercised; (ii) in Shares having a Fair Market Value equal to the aggregate Option Exercise
Price Per Share for the Option Shares being purchased and satisfying such other requirements as may be imposed by the Board; provided,
that such Shares have been held by the Optionee for no less than six months (or such other period as established from time to time
by the Board in order to avoid adverse accounting treatment applying generally accepted accounting principles); (iii) partly in
cash and partly in Shares (as described in the preceding clause (ii)); (iv) if there is a public market for the Shares at such
time, through the delivery of irrevocable instructions to a broker to sell Shares obtained upon the exercise of the Stock Option
and to deliver promptly to the Company an amount out of the proceeds of such sale equal to the aggregate Option Exercise Price
Per Share for the Option Shares being purchased, provided that in the event the Optionee chooses to pay the Option Exercise Price
Per Share as so provided, the Optionee and the broker shall comply with such procedures and enter into such agreements of indemnity
and other agreements as the Board shall prescribe as a condition of such payment procedure; or (v) through “net settlement”
in Shares. In the case of a “net settlement” of the Stock Option, the Company will not require a cash payment of the
Option Exercise Price Per Share for the Option Shares being purchased, but will reduce the number of Shares issued upon the exercise
by the largest number of whole Shares that have a Fair Market Value that does not exceed the aggregate Option Exercise Price Per
Share for the Option Shares set forth in this Agreement. With respect to any remaining balance of the aggregate Option Exercise
Price Per Share for the Option Shares, the Company shall accept a cash payment. Payment instruments will be received subject to
collection.

The transfer to the Optionee
on the records of the Company or of the transfer agent of the Option Shares will be contingent upon (i) the Company’s receipt
from the Optionee of the full purchase price for such Option Shares, as set forth above, (ii) the fulfillment of any other requirements
contained herein or in any other applicable agreement or applicable laws and regulations, and (iii) the receipt by the Company
of any agreement, statement or other evidence that the Company may require to satisfy itself that the issuance of the Shares pursuant
to the exercise of the Stock Option and any subsequent resale of such Shares will be in compliance with applicable laws and regulations.

(b)       The
Shares purchased upon exercise of the Stock Option shall be transferred to the Optionee on the records of the Company or of the
transfer agent upon compliance to the satisfaction of the Board with all requirements under applicable laws or regulations in connection
with such transfer and with the requirements hereof. The determination of the Board as to such compliance shall be final and binding
on

    	 

    	 

    

the Optionee. The Optionee shall not be deemed to be the holder of, or to have any of the rights of a holder with respect to,
any Shares subject to the Stock Option unless and until the Stock Option shall have been exercised pursuant to the terms hereof,
the Company or the transfer agent shall have transferred the Shares to the Optionee, and the Optionee’s name shall have been
entered as the stockholder of record on the books of the Company.

(c)       The
minimum number of Shares with respect to which the Stock Option may be exercised at any one time shall be 100 Shares, unless the
number of Shares with respect to which the Stock Option is being exercised is the total number of Shares subject to exercise under
the Stock Option at the time.

(d)       Notwithstanding
any other provision hereof, no portion of the Stock Option shall be exercisable after the Expiration Date hereof.

4.         Termination
of Employment. If the Optionee’s employment by the Company (or any affiliate of the Company) is terminated, the period
within which to exercise the Stock Option may be subject to earlier termination as set forth below or as set forth in that certain
Employment Agreement dated as of November 7, 2017 by and between the Company and the Optionee (as the same may be amended from
time to time, the “Employment Agreement”).

(a)       Termination
Due to Death. If the Optionee’s employment terminates by reason of the Optionee’s death, any portion of the Stock
Option outstanding on such date may be exercised, to the extent exercisable on the date of Optionee’s death, by the Optionee’s
legal representative or legatee for a period of 12 months from the date of death or until the Expiration Date, if earlier. Any
portion of the Stock Option that is not exercisable on the date of death shall terminate immediately and be of no further force
or effect.

(b)       Termination
Due to Disability. If the Optionee’s employment terminates by reason of the Optionee’s Disability, any portion
of the Stock Option outstanding on such date may be exercised, to the extent exercisable on the date of Disability, by the Optionee,
or the Optionee’s legal representative or guardian, as applicable, for a period of 12 months from the date of Disability
or until the Expiration Date, if earlier. Any portion of the Stock Option that is not exercisable on the date of Disability shall
terminate immediately and be of no further force or effect.

(c)       Termination
for Cause; Voluntary Termination. If the Optionee’s employment with the Company (or any affiliate thereof) terminates
for Cause or if the Optionee voluntarily terminates his employment, any portion of the Stock Option outstanding on such date shall
terminate immediately and be of no further force or effect. For purposes of this Agreement, “Cause” shall have
the meaning set forth in the Employment Agreement.

(d)       Other Termination.
If the Optionee’s employment terminates for any reason other than the Optionee’s voluntary termination, the Optionee’s
death, the Optionee’s Disability or for Cause, unless otherwise provided in the Employment Agreement, (i) any portion of
the Stock Option outstanding on such date may be exercised, to the extent exercisable on the date of termination, for a period
of three months from the date of termination or until the Expiration Date, if earlier, and (ii) any portion of the Stock Option
that is not exercisable on the date of termination shall terminate immediately and be of no further force or effect. In the event
of any conflict between the terms of this Section 4(d) and the terms of the Employment Agreement, the terms of the Employment
Agreement shall control and govern.

The Board’s determination
of the reason for termination of the Optionee’s employment shall be conclusive and binding on the Optionee and his representatives
or legatees.

    	 

    	 

    

5.       Termination
of Option. The Option will expire as of 5:00 pm (Central time) on the tenth anniversary of the Effective Date (the “Expiration
Date”) with respect to any then unexercised portion thereof, unless terminated earlier as set forth herein or the Employment
Agreement.

6.       Certain
Legal Restrictions. The Company shall have no obligation to the Optionee, express or implied, to list, register or otherwise
qualify the Stock Option or any of the Shares issuable upon exercise of the Stock Option. Upon exercise, the certificate evidencing
the purchased Shares shall be legended as follows:

THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE
APPLICABLE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION AND MAY NOT BE SOLD, ASSIGNED, TRANSFERRED OR PLEDGED EXCEPT IN COMPLIANCE
WITH THE REQUIREMENTS OF SUCH ACT AND THE APPLICABLE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION.

As a condition to any
transfer of Shares acquired upon exercise of the Stock Option, the Company may require an opinion of counsel, satisfactory to the
Company, to the effect that such transfer will not be in violation of the Securities Act of 1933, as amended, or any other applicable
securities laws or that such transfer has been registered under federal and all applicable state securities laws.

7.       Adjustments.
In the event that any unusual or non-recurring transactions, including an unusual or non-recurring dividend or other distribution
(whether in the form of an extraordinary cash dividend, dividend of Shares, other securities or other property), recapitalization,
stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination or other similar corporate
transaction or event affects the Shares, then the Company shall, depending on the particular circumstances, in an equitable and
proportionate manner (and, as applicable, in such equitable and proportionate manner as is consistent with Section 409A of
the Code and the regulations thereunder) either: (a) adjust any or all of (i) the number of Shares or other securities of the Company
(or number and kind of other securities or property) subject to the Stock Option, provided that the number of Shares subject to
the Stock Option shall always be a whole number; and (ii) the Option Exercise Price Per Share with respect to the Stock Option;
(b) provide for an equivalent award in respect of securities of the surviving entity of any merger, consolidation or other transaction
or event having a similar effect; or (c) make provision for a cash payment to the Optionee in lieu of the Stock Option.

8.       No
Obligation to Continue Employment. Neither the Company nor any of its affiliates is obligated by or as a result of this Agreement
to continue the Optionee in employment and this Agreement shall not interfere in any way with the right of the Company or any of
its affiliates to terminate the employment of the Optionee at any time, subject to the terms of the Employment Agreement.

9.       Amendments
to Stock Option. The Board may waive any conditions or rights under, amend any terms of, or alter, suspend, discontinue, cancel
or terminate, the Stock Option, prospectively or retroactively; provided that any such waiver, amendment, alteration, suspension,
discontinuance, cancellation or termination that would adversely affect the rights of the Optionee or any holder or beneficiary
of the Option shall not to that extent be effective without the consent of the Optionee, holder or beneficiary affected.

10.       Limited
Transferability. Unless otherwise approved by the Board, this Agreement is personal to the Optionee, is non-assignable and
is not transferable in any manner, by operation of law or otherwise, other than by will or the laws of descent and distribution.
Except as provided in Section 4(b) of

    	 

    	 

    

this Agreement, the Stock Option is exercisable, during the Optionee’s lifetime,
only by the Optionee, and thereafter, only by the Optionee’s legal representative or legatee.

11.       Reservation
of Shares. At all times during the term of the Stock Option, the Company shall use its best efforts to reserve and keep available
such number of Shares as shall be sufficient to satisfy the requirements of this Agreement.

12.       Severability.
If any provision of this Agreement is, or becomes, or is deemed to be, invalid, illegal, or unenforceable in any jurisdiction or
to either party, such provision shall be construed or deemed amended to conform to the applicable laws, or if it cannot be construed
or deemed amended without, in the determination of the Board, materially altering the intent of this Agreement, such provision
shall be stricken as to such jurisdiction or party, and the remainder of this Agreement shall remain in full force and effect.

13.       Tax
Withholding. The Optionee shall, not later than the date as of which the exercise of the Stock Option becomes a taxable event
for federal income tax purposes, pay to the Company or make arrangements satisfactory to the Board for payment of any federal,
state, and local taxes required by law to be withheld on account of such taxable event. The minimum required tax withholding obligation
may be satisfied, in whole or in part, by the Company withholding from the Option Shares to be issued a number of Shares with an
aggregate Fair Market Value that would satisfy the withholding amount due.

14.       Notices.
Notices hereunder shall be mailed or delivered to the Company at its principal place of business and shall be mailed or delivered
to the Optionee at the address on file with the Company or, in either case, at such other address as one party may subsequently
furnish to the other party in writing.

15.       Certain
Defined Terms. Although the Stock Option is not granted under the 2013 Plan, for purposes of this Agreement, the terms “Change
of Control,” “Disability” and “Fair Market Value” shall have the same meanings given to those terms
in the 2013 Plan.

16.       Governing
Law. The validity, construction and effect of this Agreement shall be determined in accordance with the laws of the State of
Delaware without giving effect to conflicts of laws principles.

17.       Successors
in Interest. This Agreement shall inure to the benefit of and be binding upon any successor to the Company. This Agreement
shall inure to the benefit of the Optionee’s administrators, executors, heirs and legal representatives. All obligations
imposed upon the Optionee and all rights granted to the Company under this Agreement shall be binding upon the Optionee’s
administrators, executors, heirs and legal representatives.

18.       Section
409A Compliance. This grant (or modification hereof) shall not provide for deferral of compensation that fails to comply with
Section 409A of the Code. Notwithstanding any provision of this Agreement to the contrary, if one or more of the payments or benefits
received or to be received by the Grantee pursuant to this Agreement would cause the Grantee to incur any additional tax or interest
under Section 409A of the Code, the Board may reform such provision to maintain to the maximum extent practicable the original
intent of the applicable provision without violating the provisions of Section 409A of the Code and the regulations thereunder.

19.       No
Fractional Shares. No fractional Shares shall be issued or delivered pursuant to this Agreement, and the Board shall determine
whether cash, other securities or other property shall be paid or transferred in lieu of any fractional Shares or whether such
fractional Shares or any rights thereto shall be canceled, terminated or otherwise eliminated.

 

    	 

    	 

    

20.       Clawback.
Notwithstanding any other provisions in this Agreement, this grant is subject to any deductions and/or clawback as may be required
to be made pursuant to any applicable law, government regulation or stock exchange listing requirement (or any policy adopted by
the Company pursuant to any such law, government regulation or stock exchange listing requirement).

 

 

[The next page is the signature
page]

 

 

 

 

    	 

    	 

    

 

IN WITNESS WHEREOF,
the parties have executed this Non-Qualified Stock Option Agreement to be effective as of the Effective Date.

 

	 	
	 	MRI INTERVENTIONS, INC.
	 	 
	 	 

	By:	
	 	
	Name:	
	 	
	Title:	
	 	
	 	
	 	

	 	
	 	Joseph Michael Burnett
	 	 

 

    	 

    	 

    

Exhibit D

 

RESTRICTED SHARE AWARD AGREEMENT

 

See Attached

 

 

 

 

 

 

 

    	 

    	 

    

THE SECURITIES GRANTED HEREIN HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS
AND MAY NOT BE SOLD, MORTGAGED, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER
THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS, OR THE AVAILABILITY OF AN EXEMPTION FROM THE REGISTRATION PROVISIONS
OF THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS.

 

MRI INTERVENTIONS, INC.

RESTRICTED SHARE AWARD AGREEMENT

 

THIS RESTRICTED SHARE
AWARD AGREEMENT (this “Agreement”) is made effective as of the 7th day of November, 2017 (the “Effective
Date”), by and between MRI INTERVENTIONS, INC., a Delaware corporation (the “Company”), and
JOSEPH MICHAEL BURNETT (the “Grantee”).

 

WHEREAS, the Company
desires to grant restricted shares of the Company’s common stock, par value $.01 per share (“Restricted Shares”)
to the Grantee, subject to the terms and conditions hereinafter set forth.

 

NOW, THEREFORE,
in consideration of the mutual covenants hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the parties hereto, intending to be legally bound hereby, agree as follows:

1.               
Grant of Restricted Shares; Grantee’s Rights. 

(a)             
The Company grants, as of the Effective Date, two hundred thousand (200,000) Restricted Shares
to the Grantee, on the terms and conditions set forth in this Agreement. This Agreement is not subject to, and the Restricted Shares
are not granted under, the Company’s 2013 Incentive Compensation Plan, as amended and restated (the “2013 Plan”).

(b)            
The Grantee shall have no rights with respect to this Agreement unless he shall have accepted
this Agreement by (i) signing and delivering to the Company a copy of this Agreement, and (ii) delivering to the Company
a stock power endorsed in blank. Upon execution of this Agreement by the Grantee, the Restricted Shares shall be issued and held
by the Company’s transfer agent in book entry form, and the Grantee’s name shall be entered as the stockholder of record
on the books of the Company. Thereupon, the Grantee shall have all the rights of a stockholder with respect to such shares, including
voting and dividend rights, subject, however, to the restrictions and conditions specified in Section 2 below.

2.               
Restrictions and Conditions.

(a)             
Any book entries for Restricted Shares granted herein shall bear an appropriate legend, as
determined by Company’s Board of Directors or a duly authorized committee thereof (in either case, the “Board”),
in its sole discretion, to the effect that such shares are subject to restrictions as set forth herein. 

(b)            
Restricted Shares granted herein may not be sold, assigned, transferred, pledged or otherwise
encumbered or disposed of by the Grantee prior to vesting.

    	 

    	 

    

(c)             
If the Grantee’s employment with the Company (or any affiliate of the Company) is terminated
prior to the vesting of the Restricted Shares granted herein, all unvested Restricted Shares shall immediately and automatically
be forfeited and returned to the Company, subject to the terms and conditions set forth in that certain Employment Agreement dated
as of November 7, 2017 by and between the Company and the Grantee (as the same may be amended from time to time, the “Employment
Agreement”).

3.               
Vesting of Restricted Shares. The restrictions and conditions in Section 2
of this Agreement shall lapse on the Vesting Dates specified in the following schedule so long as the Grantee remains in the employment
of the Company (or any affiliate of the Company) on such dates. The restrictions and conditions in Section 2 shall
lapse only with respect to the number of Restricted Shares specified as vested on such date.

	
        Incremental Number of

        Restricted Shares Vested
	 	
         

        Vesting Date

	66,666	 	On the first anniversary of the Effective Date
	16,166	 	Every three (3) months thereafter up to but not including the Final Vesting Date
	16,172	 	On the third anniversary of the Effective Date (the “Final Vesting Date”)

Subsequent to such
Vesting Dates, the Restricted Shares on which all restrictions and conditions have lapsed shall no longer be deemed Restricted
Shares. Once the restrictions and conditions have lapsed, the Company shall instruct its transfer agent to issue a stock certificate
representing the vested portion of the Restricted Shares. The Board may at any time accelerate the vesting schedule specified in
this Section 3. Notwithstanding anything herein to the contrary, in the event of a Change of Control, the Restricted Shares
shall become fully vested as of the effective time of the Change of Control. For purposes of this Agreement, the term “Change
of Control” shall have the same meaning given to that term in the 2013 Plan.

4.               
Dividends. Dividends on the Restricted Shares, to the extent declared and paid, shall
be paid currently to the Grantee.

5.               
Tax Withholding. The Grantee shall, not later than the date as of which the receipt
of this Agreement becomes a taxable event for federal income tax purposes, pay to the Company or make arrangements satisfactory
to the Board for payment of any federal, state, and local taxes required by law to be withheld on account of such taxable event.
Except in the case where an election is made pursuant to Section 6 below, the required minimum tax withholding obligations
of the Company may be satisfied, in whole or in part, by the Company withholding from the Restricted Shares to be issued a number
of Restricted Shares with an aggregate Fair Market Value that would satisfy the withholding amount due.

6.               
Election Under Section 83(b). The Grantee and the Company hereby agree that the Grantee
may, within thirty (30) days following the acceptance of this Agreement as provided in Section 1 of this Agreement,
file with the Internal Revenue Service and the Company an election under Section 83(b) of the Internal Revenue Code of 1986, as
amended (the “Code”). In the event the Grantee makes such an election, he agrees to provide a copy of the election
to the Company. The Grantee acknowledges that he is responsible for obtaining the advice of his tax advisors with regard to the
Section 83(b) election and that he is relying solely on such advisors and not on any statements or representations of the Company
or any of its agents with regard to such election.

    	 

    	 

    

7.               
Section 409A Compliance. This grant (or modification hereof) shall not provide for
deferral of compensation that fails to comply with Section 409A of the Code. Notwithstanding any provision of this Agreement to
the contrary, if one or more of the payments or benefits received or to be received by the Grantee pursuant to this Agreement would
cause the Grantee to incur any additional tax or interest under Section 409A of the Code, the Board may reform such provision to
maintain to the maximum extent practicable the original intent of the applicable provision without violating the provisions of
Section 409A of the Code and the regulations thereunder.

8.               
Adjustments. In the event that any unusual or non-recurring transactions, including
an unusual or non-recurring dividend or other distribution (whether in the form of an extraordinary cash dividend, share dividend,
other securities or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation,
split-up, spin-off, combination or other similar corporate transaction or event affects the Restricted Shares granted herein, then
the Company shall, depending on the particular circumstances, in an equitable and proportionate manner (and, as applicable, in
such equitable and proportionate manner as is consistent with Section 409A of the Code and the regulations thereunder) either:
(a) adjust the number of Restricted Shares, provided that the number of Restricted Shares shall always be a whole number; (b) provide
for an equivalent award in respect of securities of the surviving entity of any merger, consolidation or other transaction or event
having a similar effect; or (c) make provision for a cash payment to the Grantee in lieu of the Restricted Shares.

9.               
Certain Defined Terms. Although the Stock Option is not granted under the 2013 Plan,
for purposes of this Agreement, the terms “Change of Control,” “Disability” and “Fair Market Value”
shall have the same meanings given to those terms in the 2013 Plan.

10.            
Transferability. Unless otherwise approved by the Board, this Agreement is personal
to the Grantee, is non-assignable and is not transferable in any manner, by operation of law or otherwise, other than by will or
the laws of descent and distribution. 

11.            
No Obligation to Continue Employment. Neither the Company nor any of its affiliates
is obligated by or as a result of this Agreement to continue the Grantee in employment, and this Agreement shall not interfere
in any way with the right of the Company or any of its affiliates to terminate the employment of the Grantee at any time, subject
to the terms of the Employment Agreement.

12.            
Notices. Notices hereunder shall be mailed or delivered to the Company at its principal
place of business and shall be mailed or delivered to the Grantee at the address on file with the Company or, in either case, at
such other address as one party may subsequently furnish to the other party in writing.

13.            
Amendment. The Board may waive any conditions or rights under, amend any terms of,
or alter, suspend, discontinue, cancel or terminate, the Restricted Shares granted herein, prospectively or retroactively; provided
that any such waiver, amendment, alteration, suspension, discontinuance, cancellation or termination that would adversely affect
the rights of the Grantee or any holder or beneficiary of the Restricted Shares granted herein shall not to that extent be effective
without the consent of the Grantee, holder or beneficiary affected.

14.            
Governing Law. The validity, construction and effect of this Agreement shall be determined
in accordance with the laws of the State of Delaware without giving effect to conflicts of laws principles.

15.            
No Fractional Shares. No fractional shares of the Company’s common stock shall
be issued or delivered pursuant to this Agreement, and the Board shall determine whether cash, other

    	 

    	 

    

securities or other property
shall be paid or transferred in lieu of any such fractional shares or whether such fractional shares or any rights thereto shall
be canceled, terminated or otherwise eliminated.

16.            
Clawback. Notwithstanding any other provisions in this Agreement, this grant is subject
to any deductions and/or clawback as may be required to be made pursuant to any applicable law, government regulation or stock
exchange listing requirement (or any policy adopted by the Company pursuant to any such law, government regulation or stock exchange
listing requirement).

[The next page is the signature page]

 

 

 

 

    	 

    	 

    

IN WITNESS WHEREOF,
the parties have executed this Restricted Share Award Agreement to be effective as of the Effective Date.

 

	 	
	 	MRI INTERVENTIONS, INC.
	 	 
	 	 

	By:	
	 	
	Name:	
	 	
	Title:	
	 	 
	 	 
	 	

	 	
	 	Joseph Michael Burnett

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00275-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00275-of-00352.parquet"}]]